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"The kidney is so important that, in contrast to the heart and the brain, 
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The epidemic of obesity 
Hippocrates wrote: "Corpulence is not only a disease itself, but the harbinger of others", 
recognizing that obesity is a medical condition that also leads to many comorbidities (1). 
Whereas, apparently, obesity was recognized as a morbid condition in ancient times, it 
may well turn out to be the major health problem of the 21st century, due to its increasing 
prevalence and the associated morbity and mortality. Obesity is associated with an 
increased mortality in selected populations - with studies reporting a 30-70% increased 
risk of death among subjects with a body mass index (BMI) of 30 kg/m2 or higher (2-4), 
mainly due to an elevated cardiovascular risk. Several cardiovascular risk factors are 
promoted by obesity. First, it is a main factor in the increasing incidence of insulin 
resistance, and eventually type 2 diabetes mellitus. Furthermore, it exerts adverse 
influences on blood pressure and lipids. The prevalence of obesity in the United States 
and other Western countries has been steadily rising over the past two decades, a trend 
that has been linked to changing dietary habits and sedentary lifestyle (5-7) and that 
shows no signs of abating yet. This increased prevalence has been reported in both 
children and adults (5). According to the National Health and Nutrition Examination 
Survey, the prevalence of obesity (defined as BMl>30 kg/m2) has increased from 14.1% 
to 22.5% between 1971 and 1994 and to 30.5% in 2000. Currently, 64.5% of the adult US 
population is overweight (BMl>25 kg/m2) (8). The situation in the Netherlands is not as 
bad as in the USA, but nevertheless 40% of the population is overweight - 25% of them 
is obese, resulting in a prevalence of 10% obesity. The rise in weight excess is especially 
concerning in children, and in particular for those of Maroccan or Turkish descent, for 
whom the percentages of being overweight and obese are more than twice the 
percentages in Dutch children of comparable age intervals (9). Health policies aim at 
reducing the incidence by prevention programs. 
Obesity as a renal risk factor 
It has long been known that morbid obesity can, in rare cases, elicit proteinuric renal 
disease (10;11), in the absence of other (apparent) triggers for renal damage. Obesity 
is also a risk factor for renal damage in native kidney disease (11-13), in renal transplant 
recipients (14-19), and after uni-nephrectomy (20). In recent years however, it has 
become clear that the renal risks of obesity and overweight are much more widespread 
than previously assumed. Several population-based studies reported obesity to be a 
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significant and independent risk factor for long term renal function loss (21 ;22). A 
recent study by Hsu et al (23) provided further support for the detrimental influence of 
a higher BMI on long term renal function loss in the general population. Compared to 
people with a normal BMI (<25 kg/m2) the relative risk for end stage renal disease 
(ESRD)(adjusted for diabetes and hypertension) after 15 to 35 years of follow-up was 
1.72 for those who were overweight (BMI 25-29 kg/m2), 2.98 for those with class I 
obesity (BMI 30-34.9 kg/m2), 4.68 for those with class II obesity (BMI 35-39.9 kg/m2) 
and 4.99 for those with a BMI higher than 40 kg/m2 . Corresponding results were 
reported by Ejerblad et al (24), in a long-term case-control study in over 900 Swedish 
subjects, who showed that a BMI over 25 kg/m2 in otherwise healthy young men was 
associated with a 3-fold risk for end stage renal damage after long-term follow-up. 
The Table shows the impact of overweight and obesity on the risk for renal insufficiency 
in the aforementioned and 3 other large population-based trials. 
Author No. patients/population BMI Follow up Outcome 
Fox (21) 2585/community based 26.1 18.5 yrs 9.4% CKD stage 3, OR 
1.23 
lseki (22) 100.753/general 23.4 17 yrs ESRD in 404 patients, OR 
population (17.9-59.1) 2.48 and 5.81 for lowest 
and highest quartile 
of BMI, respectively 
Gelber (25) 11.104/healthy men Analysis 14 yrs 12.4% CKD stage 3, OR 
for quintiles 1.45 in highest quintile 
of BMI 
Ejerblad (24) 926/adults with CKD 25.6 (M), retro- 3-fold risk for CRF 
stage 4-5 25 (F) spective among patients with 
overweight at age 20 
Hsu (23) 320.252/adults 24.5 15-35 yrs ESRD in 1471 cases, OR 
volunteering for health (SD 4.3) 1.72 and 4.99 for lowest 




So, within little more than a decade, the perspectives of weight excess as a factor 
involved in the risk for renal damage has dramatically changed, from a rare renal 
condition in morbidly obese subjects to a highly prevalent and established risk factor 
for end stage renal function loss. Considering the epidemiology of weight excess, this 
is reason for concern from a renal perspective. If the increasing incidence of weight 
excess would translate into an increased renal risk with a time lag of 15 to 20 years, this 
would have major impact on the prevalence of end stage renal disease world wide, 
even taking into consideration the competing risk of elevated cardiovascular mortality 
that is likely to reduce the number of subjects that survive long enough to progress into 
end stage renal failure. Obviously, population health programs aimed at correction of 
weight excess should have high priority. Nevertheless, it would be overly optimistic to 
expect that this will eliminate weight excess as a renal risk factor. It would be important 
therefore, to better understand the mechanisms underlying the adverse impact of 
weight excess on the kidney in order to develop specific, renoprotective measures to 
reduce the renal risk associated with weight excess. 
Insulin resistance 
Type 2 diabetes mellitus 
Obesity L..liliii.. 




Modified from Lau DCW et al (26). 
Several factors that are usually associated with obesity, such as hypertension, insulin 
resistance and diabetes, and possibly also dyslipidemia, are assumed to account for 
part of the increased renal risk in obesity (27-30). Yet, other factors specifically related 
to weight excess are likely to be involved as well. 
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The renal effects of obesity in experimental animals and humans include both structural 
and functional adaptations. The most accurately described type of renal involvement is 
the so-called 'obesity-related glomerulopathy', with slowly progressive proteinuria, 
which can reach the nephrotic range (10;31-33). The appearance of proteinuria usually 
precedes the onset of renal function decline by several years (10;31-33). The histological 
counterpart of these clinical manifestations include focal segmental glomerulosclerosis, 
and glomerulomegaly as the most significant and frequent findings (10;31 ;32). In this 
respect, Rea et al (34) recently studied implantation biopsies in 49 obese kidney 
donors, showing larger glomerular planar surface area compared to non-obese 
controls, correlating to patient weight and urinary microalbumin excretion. Of note, the 
obese donors had higher systolic blood pressure and higher absolute iothalamate 
clearance than the non-obese donors. Glomerular size however, did not correlate with 
total corrected or uncorrected glomerular filtration rate. 
Functional changes in obesity include hemodynamic alterations, with glomerular 
hyperperfusion and hyperfiltration. An increase of glomerular filtration rate (GFR), 
effective renal plasma flow (ERPF), glomerular filtration pressure and filtration fraction 
(FF) through a dilated glomerular afferent arteriole, accompanied by a relatively 
elevated efferent arteriolar vascular tone has been repeatedly, albeit not uniformly, 
found in experimental models of obesity (35-37) and human obesity (13;38). Glomerular 
hyperfiltration, and in particular glomerular capillary hypertension has extensively been 
shown to be a driving force for progressive renal function loss in remnant kidney 
models by glomerular capillary damage, resulting in glomerular protein leakage and 
nephron loss, thus eliciting a vicious circle of progressive renal damage (39). In obesity 
models, the evidence for a pathogenetic role of glomerular hypertension is not as 
abundant as in remnant kidney models. Its relative contribution to overall renal damage, 
versus the effects of systemic hypertension, insulin resistance and dyslipidemia has not 
been fully elucidated with certainty, and may in fact vary among the different obesity 
models. 
In human obesity the renal hemodynamic profile strongly resembles the hyperfiltration 
pattern in diabetes. An elevated GFR is consistently found, with an increase in ERPF 
that is either proportional, or somewhat less, resulting in a FF that is either normal or 
elevated. In the former case, the driving force for the elevated GFR seems to be 
glomerular hyperperfusion , in the latter glomerular capillary hypertension (40). As this 
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pattern is, at least partly, reversible after rigorous weight loss functional changes are 
apparently involved. 
In diabetes hyperfiltration has been shown to precede the onset of nephropathy and is 
generally assumed to be a pathogenetic factor in the progression of renal damage 
(41-43). It should be mentioned however, that in human the evidence for an independent 
pathogenetic role of renal hemodynamics is of an indirect nature (44;45) as there are 
no prospective longitudinal data on the independent effect of the renal hemodynamic 
profile on long term renal outcome. Yet, the proven pathogenic potential of glomerular 
hypertension in animal models, together with the similarity to the renal hemodynamic 
profile in incipient nephropathy in diabetes fuel the hypothesis that renal hemodynamic 
factors, i.e. glomerular hypertension and hyperfiltration play a pathogenetic role in the 
long-term renal risk associated with weight excess. 
Multiple factors are assumed to contribute to these renal hemodynamic alterations of 
obesity, such as inappropriate activity of the renin-angiotensin-aldosterone system 
(RAAS), the tubulo-glomerular feedback response to increased proximal sodium reab­
sorption, insulin resistance (27) and possibly also inappropriate activity of the 
sympathetic nervous system and increased leptin levels (46-48). 
Renal hemodynamic measurements in human 
Glomerular hemodynamics can be measured directly by micropuncture studies in rat 
strains where the glomeruli are located exceptionally close to the surface of the kidney. 
In human, however, renal hemodynamics can only be measured indirectly. Although 
currently duplex Doppler sonography is used to estimate renal blood flow in clinical 
conditions such as renal artery stenosis, the gold standard for renal hemodynamic 
evaluation is still the measurement of the renal clearance of specific tracers. Specific 
tracers for glomerular filtration rate, such as inulin or iothalamate, are characterized by 
being freely filtered, and are devoid of tubular handling and of extrarenal routes of 
excretion. Specific tracers for renal plasma flow, such a para-amino-hippuric acid and 
its derivatives, are characterized by complete renal extraction of the tracer by active 
tubular transport, to the effect that the rate-limiting factor for clearance is the delivery 
to peritubular capillaries, i.e. renal perfusion. In our centre accurate assessment of GFR 
and ERPF is performed on a routine base as the simultaneously measured clearances 
of 1251-iothalamate and 131 1-hippurate, respectively, by the constant infusion method. 
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The simultaneous measurement has two distinct advantages. First, the plasma 
clearance of 131 I-hippurate has been shown to equal the renal clearance in case of 
perfect urine collection. Thus, the urine collection error can be derived from the ratio of 
the plasma-to-urinary clearance of 131 I-hippurate. This allows correcting for the voiding 
error for 125 I-iothalamate clearance, which considerably enhances the accuracy of the 
measurement of GFR (49). Moreover, when GFR and ERPF are measured simultaneously, 
filtration fraction (FF) can be calculated as the ratio from GFR and ERPF. FF serves as 
a helpful parameter to interpret changes in GFR in terms of the underlying hemodynamic 
changes. When a rise in GFR is primarily due to hyperperfusion, it will be associated 
with a proportional rise in ERPF and thus unaltered FF. When a rise in GFR is primarily 
due to a change in filtration pressure, this will be apparent as a rise in FF, as ERPF will 
be elevated less than GFR. As already mentioned above, an elevated filtration pressure 
is assumed to be a pathogenetic factor in long-term renal damage. For these reasons, 
FF can be considered a surrogate parameter for glomerular hypertension in man. 
Several considerations should be taken in mind when evaluating renal hemodynamics 
in obesity by clearance methods. First, the pathophysiologically relevant issue is hyper­
filtration at the single nephron level. Clearance measurements in human, however, 
reflect total filtration rate of all nephrons together, so a GFR within the normal range may 
reflect a normal filtration rate in a normal nephron number, but also an elevated filtration 
rate in a decreased number of nephrons without a possibility to distinguish between 
these conditions. Only if total GFR is elevated, glomerular hyperfiltration is present with 
certainty. Second, for comparison of renal hemodynamics between individuals GFR 
and ERPF are indexed for body dimensions, usually body surface area. However, when 
addressing possible renal effects of weight excess, this common practice could well 
induce a systematic error, as weight excess leads to a higher body surface area. Thus 
for obese individuals indexing would lead to lower renal function outcomes in 
comparison to subjects without weight excess. The validity of this approach is questi­
onable, and several authors have recommended indexing for height (50-52), especially 
for the purpose of investigating effects of obesity. In this respect assessment of FF 
provides some specific advantages. First, as it is derived from both GFR and ERPF its 
interpretation is less affected by assumptions on nephron number. Moreover, it is not 
dependent on assumptions on the best way to index for individual differences. For 
these reasons, despite its indirect nature, FF is a highly useful parameter in the study 
of renal hemodynamics in relation to weight excess. 
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Aim of the thesis 
This thesis addresses the relationship between weight excess and renal hemodynamics 
in human. Studies on the relationship between obesity and renal hemodynamics in 
humans are scarce, and mainly limited to morbid obesity, usually associated with 
insulin resistance, diabetes and/or hypertension (27;51 ;53). As recent data have shown 
that the impact of weight excess is not limited to morbid or even overt obesity, but also 
is relevant to milder forms of weight excess, the latter becomes a relevant topic for 
research as well, in particular for preventive purposes. 
The University Medical Center in Groningen has some 30 years of history of accurately 
assessing renal hemodynamics by measuring the clearances of 125 1-iothalamate and 
131 1-hippurate, as measures for GFR and ERPF, respectively (54). It is used for patient 
management in different settings of third-line referral populations, such as renal 
transplant recipients, potential kidney donors and lung transplant recipients, as well 
as for physiological studies in healthy volunteers. This setting provides the perfect 
opportunity to study the relationship between obesity, overweight and renal 
hemodynamics in different populations in more depth. 
Renal function measurements 
The gold standard for monitoring renal function is serial measurement of GFR. In 
clinical practice, however, this is not always feasible due to logistic, financial, or patient 
related problems. A more practical and cheaper way to measure renal function is by 
estimating GFR, making use of creatinine-based equations. It is known, however, that 
these equations can be biased by body dimensions. After renal transplantation body 
composition usually changes, possibly violating the assumptions underlying the renal 
function equations. In Chapter 2 we test the predictive performance of 9 renal function 
equations in a large population of renal transplant recipients, with specific emphasis on 
the demographic determinants, including age, gender and body mass index on the 
systematic error, both for cross-sectional analysis and for long-term follow-up. 
Renal hemodynamics 
As noted above, altered renal hemodynamics with glomerular hyperfiltration was 
reported mainly in morbid obesity (13;38). As the risk for long-term renal function 
apparently occurs already at less severe degrees of weight excess, starting at a BMI 
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>25 kg/m2, in the general population as well as in transplant recipients (17;18), it would 
be important to explore the possible mechanisms underlying the increased renal risk in 
moderate weight excess. So far, it has not been established whether a mild or moderate 
degree of weight excess is associated with altered renal hemodynamics as a candidate 
mechanism for long-term renal function loss. Furthermore, in morbid obesity hypertension 
and/or insulin resistance are usually simultaneously present, so it is uncertain whether 
documented renal hemodynamic abnormalities are due to the effects of hypertension, 
insulin resistance or their combination, or whether the weight excess has renal effects 
independent of these factors as well. Therefore, in Chapter 3 we investigated the 
association between body mass index and renal hemodynamics in healthy adults, with 
a body mass index not exceeding 30 kg/m2 , and normal blood pressure, to see whether 
a higher body mass index would be associated with a renal hyperfiltration and/or hyper­
perfusion pattern. 
Obesity and overweight of the recipient are associated with renal risk after transplantation 
as well. Whether this increased renal risk is due to altered renal hemodynamics, i.e., a 
hyperfiltration pattern in the transplanted kidney, has not been established. In fact, the 
impact of weight excess on renal hemodynamics in the transplanted kidney has not 
been established either. In this respect, we want to emphasize that it is not warranted 
to simply extrapolate data from native kidneys to transplanted kidneys, as multiple 
factors, such as cyclosporin use, the single kidney state, and presence of intrinsic renal 
damage all may affect hemodynamics in the transplanted kidney, and thus overrule 
possible weight-related factors. Moreover, as opposed to native kidneys, the transplanted 
kidney is denervated. Of note, the transplanted kidney also provides an interesting 
model system, where the genetic background of the kidney and the recipient are 
different. So for various reasons it would be relevant to establish whether a higher 
recipient BMI is associated with a specific renal hemodynamic profile. Moreover, it 
would be important to establish whether the association between high BMI and worse 
renal outcome in transplant recipients can be attributed to the renal hemodynamic 
profile. These questions are addressed in Chapter 4, describing the cross-sectional 
association between BMI and renal hemodynamics in transplant recipients, as well as 
long term outcome data, in relation to BMI and renal hemodynamics, respectively. 
As noted above, for the purpose of detecting hyperfiltration the interpretation of whole 
kidney clearance measurements can be cumbersome and hyperfiltration at the single 
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nephron level cannot be excluded if GFR is normal or decreased. Therefore, additional 
strategies have been developed to address the issue of hyperfiltration . These strategies 
start from the assumption that a decrease in filtration reserve is a sign of hyperfiltration. 
The normal kidney has a considerable filtration reserve, as for instance apparent from 
the immediate rise in GFR and ERPF in the remaining kidney after donation, from the 
considerable rise in GFR and ERPF in pregnancy, and from the responses to several 
renal vasodilators . Several protocols have been developed to assess the reserve of 
filtration and perfusion , respectively, from the renal responses to specific renal 
vasodilators , alone or in combination (55-57). In our centre, the renal responses to 
dopamine, amino acids and their combination have been routinely in use for a long time 
for this purpose. Dopamine elicits preferential efferent vasodilation (resulting in a rise in 
ERPF that exceeds the rise in GFR), whereas amino-acids give predominantly afferent 
vasodilation , resulting in a prominent rise in GFR, with a less prominent or unchanged 
ERPF. The combination of the two gives both afferent and efferent vasodilation and 
marked increases in GFR and ERPF that exceed those with the two separate 
compounds. Renal reserve filtration capacity may be relevant for maintenance of renal 
function after loss of functional renal mass by disease, or after kidney donation . In this 
concept, loss of nephrons, by for instance kidney donation, or by the aging process, 
would be associated with reduction of renal reserve capacity by using the available 
reserve for maintenance of renal function . Moreover, hyperfiltration could be 
hypothesized to be unmasked by a loss of reserve capacity, and accordingly absence 
or decrease of filtration reserve could be a marker of sustained single nephron 
hyperfiltration that may have maladaptive consequences by damaging remnant 
g lomeru li . To see whether the renal hemodynamic pattern associated with weight 
excess might reflect hyperfiltration , in Chapter 5 we investigated the association 
between B M I, renal hemodynamics and renal reserve capacity. The hypothesis to be 
tested was that a higher B M I wou ld be associated with a decrease in reserve capacity. 
The impact of other possible factors that might decrease reserve capacity, such as 
older age, and loss of nephrons by uninephrectomy was addressed as well. To this 
purpose we measured renal hemodynamics and renal reserve capacity before and 
after kidney donation, with analysis for determinants of reserve capacity. 
18 
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General discussion and summary 
In Chapter 6 we provide an overview of the current literature on the impact of obesity 
and overweight on renal hemodynamics, putting the findings from our own studies in a 
broader perspective. We discuss potential underlying mechanisms, implications for 
long-term renal risk and possible strategies for intervention. 
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CHAPTER 2 
Abstract 
Background. Creatinine-based equations are available to estimate GFR. After renal 
transplantation body composition usually changes , thus specific validation is required 
for transplant recipients .  
Methods and results. Nine equations were compared with iothalamate GFR at  1 year 
after transplantation in 798 recipients. Equations were analyzed for precision, bias and 
accuracy. Sources of bias were analyzed by uni- and multivariate analysis, with body 
mass index (BMI), age and sex as independent variables and bias as dependent 
variable. Four hundred and seventy-eight patients were studied to assess whether the 
equations can be used to monitor renal function over time. Predictive performance was 
modest for all equations. MORD and Jelliffe 2 were the best predictors of GFR. Bias 
was significantly related to BMI, age and gender in most equations. Multivariate 
analysis confirmed their independent contribution to the bias of MORD, Jelliffe 2, and 
most other equations. Over time, bias was relatively stable at group level, but predictive 
performance in individuals was modest. 
Conclusions . The predictive performance of renal function equations is modest in 
renal transplants, which hampers their use for accurate assessment of renal function 
in the individual. The role of patient factors in the systematic error suggests that 
development of better equations should be feasible by better incorporation of these 
factors. 
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Introduction 
Glomerular filtration rate (GFR) can be precisely measured by specific filtration markers 
such as inulin, 125 1-iothalamate, 51Cr-EDTA, 99mTc-DTPA and iohexol. These measurements, 
however, are laborious and expensive, and therefore, in clinical practice GFR is usually 
estimated from serum creatinine, using renal function equations that include 
antropometric indices such as age, weight and gender to account for between­
individual differences in muscle mass and the consequent differences in creatinine 
generation. Many equations are available, most of which were developed in populations 
with native kidney disease (1-18). T he predictive performance as well as the 
shortcomings of creatinine-based renal function equations have been subject of 
several recent reviews (19;20). 
After renal transplantation body composition often changes, with a high prevalence of 
obesity and loss of muscle mass due to steroid use - which could violate the 
assumptions underlying the creatinine-based renal function equations. Thus, for renal 
transplant recipients specific validation of renal function equations would be required. 
Several studies addressed this issue (21-25), indicating a relatively poor predictive 
performance of renal function equations in the transplant population. However, these 
studies included only relatively small populations, and only evaluated a small number 
of equations. Furthermore, in these studies the factors underlying the poor predictive 
performance, and the consequences for the clinical monitoring of individual patients 
over time were not analyzed. In the present study, therefore, we studied the predictive 
performance of nine renal function equations in a large single center population of renal 
transplant recipients, and analyzed for determinants of the systematic error. Moreover, 
to assess the suitability of equations to monitor renal function over time, the stability of 
bias over time, and the accuracy of the equations to predict the change in GFR over 
time were studied in 478 patients with a follow-up to 5 years after transplantation. 
Methods 
Patients 
The study group consisted of 798 renal transplant recipients (722 from cadaveric and 




years) in whom renal hemodynamic measurements had been routinely performed in 
our department 1 year after transplantation. The patients were transplanted between 
1984 and 2002. The study group was selected ou t of 1798 patients - the total number 
transplanted from 1968 until 2002. Of 997 patients renal hemodynamic measurements 
at 1 year after transplantation were available. Of these patients ,  199 could not be 
included because relevant data on certain hemodynamic parameters were missing .  
The routine immunosuppressive regimen is described in detail elsewhere (26). 
Methods 
Renal hemodynamic measurements 
Glomerular filtration rate (GFR) was measured by constant infusion of 125 I-iothalamate, 
with correction for voiding errors by simultaneous measurement of the clearance of 
131 I-hippuran as described by Danker et al and Apperloo et al (27;28). B riefly, an 
intravenous canula was inserted for tracer infusion at 8 a.m. The infusion fluid consisted 
of 4 M B q 131 I-hippuran and 3 M Bq 125 I-iothalamate per 100 ml saline. First, a priming 
solu tion of 0 .4 ml/kg body weight was admin istered plus an extra 0.6 M Bq 
125I-iothalamate to ensure steady state of the plasma tracers within the time frame of the 
measurement. Thereafter, a continuous infusion was started. After a stabilization period 
of 2h, two 2-h clearance periods followed. GFR was measured as the urinary clearance 
of 125 I-iothalamate (UV/P) and corrected for voiding errors by multiplying UV/P iothal by the 
ratio of plasma clearance of 131 I-hippuran to urinary clearance of 131 I-hippuran. 
This correction method is based on the fact that, during steady state, the plasma 
clearance of 131 I-hippuran equals its urinary clearance when urine collection is perfect. 
Thus, the voiding error is can be calculated from the ratio of urinary clearance and 
plasma clearance of 131 I-hippuran. This GFR measurement has a day-to-day coefficient 
of variation of 2.2% . Serum creatinine levels were determined by an alkaline picrate 
creatinine assay (Jaffe), which has a day-to-day variability of 4% in our laboratory. 
Renal function equations 
As a first, screening, step, 18 equations (Cockcroft, Edwards , Mawer, B jornsson, Hu ll, 
Salazar, Nankivell 1 (developed for kidney transplant recipients), Nankivell 2 (developed 
for combined kidney/pancreas transplant recipients), Baracskay, Walser, Jelliffe 1* and 
2*, Gates*, Agarwal*, Toto*, Nguyen*, simplified MORD* and the recently published 
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equation developed by Rule* et al (1-18) were analyzed for predictive performance from 
the data obtained at 1 year after transplantation. 
These equations are given in Appendix 1. Equations were analyzed for precision (R2 , 
defined as the scatter of the series of observations), accuracy (defined as the 
percentage of subjects within 30% of true GFR, i.e 1 25I-iothalamate clearance) and bias 
(calculated as the mean prediction error (ME), defined as ME = 1/N :E (predicted value 
- true value). All equations were tested against true GFR,  including equations predicting 
creatinine clearance. Equations predicting GFR per BSA (indicated by *) were tested 
against GFR per BSA. Walser and Hull were tested against GFR per 3 m2 and GFR per 
70 kg respectively. 
Selection of equations for detailed analysis 
A selection of the equations was used for further analysis. The MORD, Jelliffe 2, Jelliffe 
1, Gates, Cockcroft, Hull and Mawer were selected because they are reviewed in six 
papers or more (a criterion also used in the DOOi guidelines review on the use of renal 
function equations (20)) and in our population had an overall predictive performance 
(30% accuracy) above 70%. Nankivell 1 was chosen because it was especially 
developed for the renal transplant population. Finally, we included the recently 
published equation of Rule et al (15), as this equation is anticipated to provide a better 
renal function estimate in subjects with mild renal function impairment. 
The 10 and 30% accuracy of the non-selected equations was: Salazar: 31 and 71%; 
Bjornsson: 33 and 70%; Agarwal 17 and 51%; Toto 18 and 50%; Baracskay 15 and 39%; 
Nguyen 4 and 13%; Edwards: 36 and 85 %; Walser 30 and 82 %; Nankivell 2: 30 and 
80%, respectively. The sources of systematic error in these non-selected equations 
were comparable to those of the selected ones, but for the sake of conciseness these 
data are not presented in the paper. 
Predictive performance over time 
The suitability of equations to monitor renal function over time was tested in all 478 subjects 
in whom data were available at 2 and 5 years as well, in addition to data at 1 year after 
transplantation. First, the mean bias at years 1, 2 and 5 was calculated and tested for 
changes over time. Second, to test the suitability for follow-up we assessed the predictive 




Statistical computations were performed using SPSS, version 12 .0 software (SPSS Inc . ,  
Chicago, IL, USA). To test for the sources of the systematic error univariate and 
multivariate analysis was performed. For univariate analysis the population was divided 
in tertiles of B M I, age and GFR, respectively. The difference in bias between the tertiles 
was assessed by analysis of variance (ANOVA). The difference in bias between men 
and women was tested by ANOVA as well. Multivariate analysis was used to identify 
patient characteristics that were independent determinants of the systematic error. 
This was analyzed by multilinear regression analysis, with bias as the dependent 
variable and B M I, age and sex as independent variables . To test whether bias changed 
over time, repeated measures analysis by general linear modeling was performed in the 
subgroup with a follow-up to 5 years after transplantation , with bias as the dependent 
variable. A two-sided p-value less than 0 .05 was considered statistically significant. 
Results 
Overall predictive performance 
Patient characteristics are given in Table 1. Mean body mass index ( B M I) was 25.6 
(±4 .0) kg/m2 . Obesity ( B M I >27.0 kg/m2) was present in 32% of the patients (n=252). 
Table 2 presents the overall predictive performance of the nine selected equations, 
calcu lated from the data at one year after transplantation . Predictive performance is 
expressed as precision (R2, depicted for individual patients in Figure 1), bias (the mean 
prediction error) and 10% and 30% accuracy (the % of values within 10% and 30% of 
the true value, respectively), ranked by 30% accuracy. It shows , first, that the non­
systematic error, as reflected by the precision , is relatively large for all equations .  
Second, the average systematic error, i .e .  bias or prediction error, appears small for 
most formula, with small confidence intervals as well, probably due to the large number 
studied. However, the standard deviation of the prediction error is large. This implicates 
that for individual patients the estimates can be highly inaccurate. Finally, the predictive 
performance of creatinine clearance measured by 24-h urine collection, was worse 
than for the tested equations .  
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Mean±SD Range 
Male/female 453/345 
Age (years) 44±13 1 4-77 
BM I  (kg/m2) 25.6±4.0 1 5.8-46 .6  
MAP (mmHg) 108±1 2 73-1 67 
GFR (ml/min) 55±1 8 1 8-1 15  
Serum creatin ine (µmol/L) 1 45±40 68-267 
Creatinine clearance (ml/min) 64±21 1 6-146 
Formula Precis ion B ias 95% CI Range Accuracy 
1 0% 30% 
M ORD 0 .63 -3 .2 -3.9/-2.5 -30.4/35.5 38% 88% 
Jel l iffe 2 0.60 -1 .4 -2.1/-0.7 -37.7/30.9 36% 88% 
Jel l iffe 1 0.63 -0.9 -1 .6/-0.2 -33 .2/38 .0  37% 87% 
Gates 0.60 -1 .6 -2.4/-0.9 -34.6/44.8 40% 87% 
Nankivel l  1 0.64 5.8 5.1/6.8 -28 .0/39.8 35% 76% 
Cockcroft-Gault 0.61 6.3 5 .4/7.1 -34.6/50.3 36% 76% 
Hul l  0.63 6 .5 5 .7/7.2 -39.5/45 .0 35% 74% 
Mawer 0.63 7.4 6.6/8 .2 -33 .6/50 .0 35% 73% 
Rule 0.65 7.4 6.5/8 .3  -4.7/68.5 29% 72% 
Creatinine clearance 0.55 9 .3 8 .3/10 .3 -37.0/83.0 23% 66% 
Sources of systematic error 
As apparent from Figure 1, for most equations the prediction error is not stable over the 
different levels of true GFR. We quantified this by comparing the prediction errors for 
tertiles of true GFR for all equations as shown in Figure 2. Bias was significantly and 
considerably different for the different tertiles of GFR for all equations. Remarkably, for 
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Scatter plots, showing the correlations between the selected equations and the measured GFR.  
The dashed l ines represent the l ines of  identity. 
The impact of BMI, age and gender, respectively, on the systematic error is shown in 
Figures 3a-c. Figure 3a shows mean values for bias for all equations (ranked by 30% 
accuracy) by a break-up according to tertiles of BMI. Mean BMI for the increasing 
tertiles was: 21.7 (range 15.8-23.7), 25.3 (range 23.7-26.8) and 30.0 (range 26.8-46.6) 
kg/m2 • It shows that BMI significantly affects bias in all but three equations. It is also 
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MORD * 
Jell iffe 2 * 
Jelliffe 1 * 
Gates * 
Nankivell 1 * 
Cockcroft * 
Hul l * 
Mawer * 
Rule * 
-1 5 -10 -5 
Bias 
■ GFR 3 (mean 75) 
□ GFR 2 (mean 54) 
GFR 1 (mean 38) 
* indicates P<0.05 
10 15 
Univariate analysis showing the mean values for bias (ml/min) for the selected equations 
(ranked by 30% accuracy) by a break-up according to terti les of GFR.  
G FR 1 :  38 (range 1 8-46) ml/min 
GFR 2: 54 (range 47-61)  ml/min 
GFR 3 :  75 (range 62-1 1 5) ml/min 
* B ias signif icantly different across the terti les (AN OVA, p< 0.05). 
B M I  Age 
R2 Beta p Beta p Beta 
MORD 0 .073 -0 .121 0 .001 -0.007 0 .832 0 .241 
Jel l iffe 2 0.1 71 -0.1 02 0.002 -0.356 <0.001 -0.1 34 
Jel l iffe 1 0 .1 1 5  -0.1 1 8  0.001 0.329 <0.001 -0 .930 
Gates 0.1 49 -0.1 1 2  0.001 0.006 0.870 0.371 
Nankivell 1 0 . 101  -0 .1 67 <0.001 0 .282 <0.001 0.1 28 
Cockcroft 0 .266 0 .393 <0.001 -0.423 <0.001 0 .D78 
Hul l  0 . 206 0. 279 <0.001 -0 .425 <0.001 0 .032 
Mawer 0 .248 0.404 <0.001 -0.396 <0.001 0.01 7 
Rule 0.044 -0.1 1 8  0 .001 -0 .108 0.003 -0.1 14  
Sex 
Table showing the models for the different equations obtained by multi l inear regression analysis. 
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Hul l * 
Mawer * 
Rule * 
- 1 5  .5 1 5  
Bias 
BMI ■ BM I  3 (mean 30,0) □ BMI 2 (mean 25,3) 
■ BMI 1 (mean 21 ,7) 
* indicates P< 0 .05 
25 35 45 
Univariate analysis showing the mean values for bias (ml/m in) for the selected equations 
(ranked by 30% accuracy) by a break-up according to terti les of BM I .  
BMI  1 :  2 1 .7 (range 1 5 . 8-23.7) kg/m2 
BMI  2: 25 .3 (range 23.7-26 .8) kg/m2 
BMI  3: 30.0 (range 26.8-46.6) kg/m2 
* B ias s ign ificantly different across the tert i les (AN OVA, p<0.05) .  
apparent  that the effect of BMI on bias for the two most widely used equations, the 
MORD equation and the Cockcroft-Gault equation, is opposite, with underestimation of 
GFR at high BMI by the MORD, and overestimation of GFR at high BMI by the Cockcroft­
Gault equation. 
Figure 3b shows bias by a break-up according to age. Mean age per tertile was 28.4 
(range 14-38) years, 45.3 (range 39-51) years and 58.8 (range 52-77) years, respectively. 
Again, in all but one equation the systematic error is significantly affected by age. 
Finally, Figure 3c gives mean bias by a break-up according to gender, showing that 
gender has a significant effect on bias in most equations. 
Multivariate analysis was performed to see whether the patient characteristics BMI, age 
and sex were independent determinants of the prediction error, or whether there might 
be interdependency. An outline of the models is given in Table 3, showing that BMI was 
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MORD * 
Jelliffe 2 * 
Jelliffe 1 * 
Gates 





-15 -5 15 
Bias 
AGE ■Age 3 (mean 59) 
□ Age 2 (mean 45) ■ Age 1 (mean 28) 
* indicates P<0.05 
25 35 45 
Univariate analysis showing the mean values for bias (ml/min) for the selected equations 
(ranked by 30% accuracy) by a break-up according to tertiles of age. 
Age 1: 28.4 (range 1 4-38) years 
Age 2:  45.3 (range 39-51) years 
Age 3: 58.8 (range 52-77) years 
* Bias signif icantly different across the terti les (ANOVA, p<0.05). 
an independent determinant of the model explaining bias for most equations, age for 
all but two equations, and gender for all but two equations. 
Predictive performance to monitor renal function over time 
To test the suitability of renal function equations to monitor renal function over time, 
first, in 478 recipients in whom GFR was also measured at 2 and 5 years after 
transplantation, we analyzed the course of the prediction error over time. Mean values 
for bias (±SE) at 1, 2 and 5 years after transplantation are given in Figure 4 (continuous 
lines). As the cross-sectional analysis at year 1 had shown that GFR and the BMI were 
determinants of the prediction error, we also evaluated whether the mean prediction 
error might be more stable over time in the subgroups with stable GFR (less than 10% 
change, n=215, broken lines) and stable BMI (less than 5% change, n=343, dotted 
lines), respectively. For the whole patient group, generally, the mean bias was fairly 
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-1 5 1 5  
Bias 
SEX ■ Female 
□ Male 
* indicates P<0.05 
30 45 
Univariate analysis showing the mean values for bias (ml/min) for the selected equations (ranked by 30% 
accuracy) by a break up according to gender. 
* Bias significantly different across the tertiles (ANOVA, p<0 .05). 
observation period. On repeated measurement analysis, nevertheless, the small change 
in prediction error over time reached statistical significance for the MORD, Jelliffe 1 and 
2, Gates and Nankivell equations (all p<0.001). This was similarly true for the subgroups 
with stable BMI and stable GFR, respectively (p<0.001). For the Cockcroft-Gault, Hull, 
Mawer and Rule equation, bias did not change significantly over time. 
Finally, we analyzed the accuracy of the equations in predicting the change in GFR over 
time. The mean change in GFR between years 1 and 5 was -1.9±15.1 ml/min (Table 
4), whereas the mean changes estimated by the different equations ranged from +0.5± 
12.1 ml/min (Jeliffe 1) to -2.3±12.3 ml/min (Hull), which was not significantly different 
from the change in true GFR. However, the precision of the equations to predict a 
change in true GFR from a change in estimated GFR was relatively poor, ranging from 
an R2 of 0.49 (MORD, Jelliffe 1, Gates and Hull) to 0.54 (Nankivell 1, Cockcroft-Gault 
and Mawer). Whereas mean bias was small, the confidence intervals were wide, and 
overall predictive performance was poor with a 30% accuracy that did not exceed 24% 
(Mawer). Data for individual patients are given in Figure 5, providing the correlations of 
the % change in true GFR with the % change in equation-estimated GFR, and with % 
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Graphs showing mean bias (ml/min, ±SE) at years 1 ,  2 and 5. Continues l ines: mean values for all 478 
patients of whom hemodynamic measurements were avai lable at years 1 ,  2 and 5. Broken lines represent 
the subpopulation with a stable GFR (n=21 5), dotted line represents the subpopulation with a stable BMI  
(n=343). The dashed l i ne  indicates the  zerovalue for  bias, so values above the  dashed l i ne  impl icate that the  
equation overestimates true GFR, and values below the  l i ne  that the  equation underestimates true GFR.  
change in reciprocal of serum creatinine, respectively. It shows a relatively wide scatter 
of individual values, with R2 values for the equations ranging from 0.49 (Rule) to 0.57 
(Cockcroft-Gault and Mawer). For the reciprocal of serum creatinine the R2 (0.51) was 




Equation Delta (mean±SD) Precision Bias 95% Cl Range 30% Accuracy 
M O RD -0.5±10 .9 0 .49 1 .1 0 .2/2.0 -38 .2/35 .3  21 % 
Jell iffe 2 -1 .9±9 .8  0 .50 -0 .3 -1 .2/0 .6 -36.1/29.7 20% 
Je lliffe 1 0 .5±12.1 0 .49 2 .2  1 . 2/3.1 -39 .0/38.0 2 1% 
Gates -0.5±1 1 .3 0 .49 1 . 2 0 .3/2.1 -40.5/35 .9  22% 
Nankivell 1 0 .3±12 .0 0 .54 1 .6 0 .6/2 .5  -41 .1/33.3 22% 
Cockcroft-Gault -1 .4±13 .4 0 .54 0 .4 -0.5/1 .4  -47.3/42.4 22% 
Hu l l  -2 .3±1 2.3 0 .49 0.1 -0 .7/1 .0 -40.0/28 .4 22% 
Mawer -1 . 9±1 4.2 0 . 54 -0.1 -1 .0/0 .9 -49.9/43 .9 24% 
Rule -1 .4±17.1 0 .44 0 .3  -0 .9/1 .4  -51 .4/41 .3  20% 
lothalamate GFR -1 .9±1 5.1 
Discussion 
The overall predictive performance of renal function equations in our renal transplant 
population was modest to poor. On group level, predictive performance was acceptable 
for several equations, but individual assessment of renal function was relatively poor for 
all equations, which hampers the use of equations in clinical practice, both for 
cross-sectional assessment and for long term follow-up. On univariate and multivariate 
analysis the patient characteristics age, gender and BMI were significant determinants 
of the systematic error. M oreover, the systematic error was dependent on the level of 
true GFR .  As the systematic error can in principle be corrected for, these data indicate 
that it should be feasible to develop more accurate renal function equations. 
Our study provides the largest transplant population analyzed so far. Several prior 
smaller s tudies recently evaluated the performance of specific renal function equations 
in transplant populations, with a comparable outcome as to overall predictive 
performance (21-25). At variance with these prior studies, the sample size of our 
population allows for analysis of the determinants of bias. This is relevant, as, in 
contrast to the random error, the systematic error can in principle be corrected for. 
Patient characteristics were involved in the systematic error in all equations, including 
38 
PREDICTIVE PERFORMANCE OF RENAL FUNCTION EQUATIONS IN RENAL TRANSPLANT RECIPIENTS: AN ANALYSIS OF PATIENT FACTORS IN BIAS 











.s -1 00 - / R Sq Uneer = 0,509 
.!!! "-,��,�-.,-�,-�,-�, --.--', 















, ' 0 ll, o 
o, 
,. 
,. R Sq Unaar = 0,509 
-100 -50 0 50 100 150 200 













R Sq Unear = 0,509 -100 - ,,, "-,��,--.,-�,-�,-�,--, 
-100 ·50 0 SO 100 150 200 












,. R Sq Unear = 0,509 
-100 -50 0 50 100 1 50 200 
Delta GFR (%) 
f ,, r: ,:._,,/ i :: ,,:'./ 
� 0 - � 
0 
0 •11, 8 0 ° g. 
ai s 0 0 s 0 






:" co O ��• 
_100 _ ,,, R Sq Unear a 0,509 _100 / R Sq Unear = 0,509 _100 ,,, R Sq Unear =-: 0,509 








-1 00 -50 0 50 100 150 200 
Delta GFR (%) 
200 
150 
-100 -50 0 SO 1 00 1 50  200 
Delta GFR (%) 
,,, f 1: ,(' 











R Sq Un ear = 0,509 .100 R Sq Uneer = 0,509 
-1 00  -50 0 SO 100 150 200 -1 00 -50 0 SO 1 00 150 200 










-100 .50 0 50 100 150 200 
Delta GFR (%) 
/ 






R Sq Unear = 0,509 
-100 -so O SO 100 1 50 200 
Delta GFR (%) 
Graphs showing correlations between % change in true GFR (X-axes) between years 1 and 5 and the % 
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the 478 patients of whom iothalamate clearances were available at years 1, 2 and 5. 
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those with the best predictive performance. The patient characteristics age and gender 
are components of all equations, representing factors that modify muscle mass and 
hence creatinine generation and serum creatinine for a given renal function. Our analy­
sis suggests, however, that the available equations do not adequately account for this 
relationship in the transplant population. BMI affected predictive performance as well. 
We analyzed for its impact as body weight is used in most equations to reflect muscle 
mass, without however, taking into account the impact of obesity on the estimation of 
muscle mass for a given body weight. The role of BMI as a determinant of the systematic 
error, therefore, was anticipated. It may be of clinical relevance that the two most 
widely used equations, the MORD and the Cockcroft-Gault, had opposite effects on the 
BMl-related error in renal function estimate, with progressive underestimation at higher 
BMI by the MORD, as compared to progressive overestimation of renal function at 
higher BMI by the Cockcroft-Gault equation. The systematic error was also dependent 
on the level of GFR. These data in transplant recipients are wel l  in line with a recent 
analysis in a large population of European renal patients (without transplant recipients) 
showing that the biases of the MORD and Cockcroft-Gault equations were significantly 
different for subgroups of age, gender, BMI and level of GFR (29). 
Taken together, the impact of simple and generally available patient factors on the 
systematic error indicates that it should be feasible to develop a renal function equation 
with better predictive performance, by more adequately incorporating these 
demographic factors into the equation. This should be subject of future analysis, with 
probably an even larger number of measurements. 
Our data derive from a single academic center and were obtained from the routine renal 
hemodynamic measurements in our transplant population. GFR was measured as the 
clearance of 125 1 -iothalamate, with correction for voiding errors by the clearance of 
simultaneously infused 131 1 -hippuran. This method has a day-to-day variability of only 
2.2% (27). The single center set-up has the additional advantage of a uniform method 
for creatinine assessment, for which the day-to-day variability is 4%. We did not attempt 
to calibrate our creatinine measurements against that of other laboratories, as, in order 
to be valid, this should have been done for all different laboratories where the equations 
were originally developed, which was not feasible. Nevertheless, whereas the nominal 
values of estimated GFR might be somewhat modified by a different creatinine 
assessment, our data allow a comparative assessment of the equations in single center 
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setting, and a solid assessment of the predictive performance over time. The impact of 
calibration of serum creatinine measurements was recently re-emphasized by data by 
Hallan et al (30). In their study the MORD equation underestimated GFR in a population 
with mild renal insufficiency, however, after recalibrating their serum creatinine values 
the systematic error was reduced and accuracy improved. This suggests that calibration 
of serum creatinine provides another possibility for better performance of renal function 
equations. It moreover illustrates a possible pitfall when the performance of an equation 
that has been developed in a specific population is tested in another one. In our 
analysis, for instance, the predictive performance of the MORD equation, as well as of 
the Rule equation, lagged behind their performance in the original publications. This 
may be due to calibration factors, but also to differences in population characteristics 
(such as the ones identified here as confounders, but possibly also unidentified ones). 
The need to test even well-validated equations in other, large populations in order to be 
able to assess their generalizability has therefore been emphasized (20). 
As to the clinical applicability of renal function equations, a distinction can be made 
between the assessment of group data and individual renal function assessment. 
In clinical epidemiology and clinical trials, the random error can be compensated for by 
larger patient numbers. The systematic error unfortunately cannot be accounted for 
by larger numbers. However, as to the bias induced by patient factors such as age and 
gender, the error can hopefully be distributed equally over the different patient groups, 
as randomization of patients usually takes into account age and gender. Our data 
indicate that for studies using renal function equations it would be useful to ensure that 
also BMI and level of GFR are equally distributed over the patient groups. 
For epidemiological purposes, recent data from our group, obtained in the general 
population, illustrate the impact of the error inherent to patient characteristics for the 
outcome of renal epidemiological studies using different renal function equations (31). 
For individual renal function assessment the problem of an accurate estimate was 
stated to be even larger, as underlined by several recent studies in different populations 
(32;33). Accordingly, these authors recommend not to rely on renal function equations 
for individual assessment, but to perform a true GFR instead, which is fully in line with 
our data in the transplant population. 
We also evaluated the performance of the equations over time. At group level the mean 
change in GFR over a period of 4 years was well-reflected by all tested equations. This 
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is somewhat at variance with recent data by Gaspari (21). In a population of 81 
transplant recipients they found that the rate of GFR decline between 6 and 21 months 
after transplantation was significantly higher for the tested equations than for the 
reference method, iohexol clearance. The reasons for the discrepancy with our findings 
are not immediately apparent, but may relate to differences in reference method, time 
elapsed after transplantation, or differences in patient population . Our data suggest 
that, within the time frame tested, renal function equations can be of use for follow-up 
of renal function in transplant recipients on the level of group data, provided that the 
sample size is sufficiently large. Obviously, for longer follow-up additional validation 
would be needed. Unfortunately, for individual follow-up of renal function over time the 
performance of renal function equations was disappointing .  This could raise the 
question whether, for individual monitoring of renal function , the equations have any 
added value over serum creatinine only. In this respect our data showed that the 
correlation between % change in reciprocal of serum creatinine with the % change in 
GFR was more or less similar to that of most tested equations, refuting an added value 
of the equations for individual monitoring.  
We conclude that the predictive performance of renal function equations is modest in 
the transplant population as a whole. For the best performing equations, the observed 
accuracy can be considered acceptable for, for instance, comparative clinical trials, 
provided that sample size and randomization allow for an equal distribution of the 
sources of systematic error (age, sex, B M I  and GFR) over the groups. For individual 
patients however, the relatively low accuracy hampers accurate assessment of renal 
function by the tested equations, also for individual follow-up. Finally, the role of the 
systematic error indicates that better incorporation of body dimensions, age and 
gender will allow to develop better renal function equations with a better predictive 
performance in the renal transplant population . 
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Screat = serum creat in ine (mg/dl) 
Pcreat = serum creatin ine (mmol/L) 
Urea = serum urea (mmol/L) 
BW = body weight (kg) 
Ht = height (m) 
Height = height (cm) 
BMI = kg/m2 
Baracskay et al (ml/min) 
4,420/pcreat + 88 - age 
Bjornsson (ml/min) 
Male: { [27 - (0.1 73 * age)] * BW * 0.07}/screat 
Female: { [25 - (0 . 175 * age)] * BW * 0.07}/screat 
Cockcroft-Gault (ml/min) 
Male: [(1 40 - age) * BW]/72 * screat 
Female: correction factor 0 .85  
Edwards and Whyte (ml/min) 
Male: (94.3/screat) - 1 . 8 
Female :  (69 .9/screat) + 2 .2  
Hull (ml/min/70 kg) 
Male:  [(145 - age)/screat] - 3 
Female: correction factor 0 .85  
Mawer (ml/min) 
Male:  {weight * [29.3 - (0.203 * age)] * [1 - (0.03 * screat)] }/(1 4.4 * screat) 
Female: {weight * [25 .3 - (0.1 75 * age)] * [1 - (0.03 * screat)]}/(1 4.4 * screat) 
Nankivell 1 (ml/min) 
Male: 35 + 6700/pcreat + BW/4 + urea/2 - 1 00/height (m)2 
Female: 25 + 6700/pcreat + BW/4 + urea/2 - 1 00/height (m)2 
Nankivell 2 (ml/min) 
Male: 71 .4 + (5,520/pcreat) + (0 . 27 * BW) - (age/2) - {0.29 * height) 
Female: 50.4 + (5,520/pcreat) + (0.27 * BW) - (age/2) - (0.29 * height) 
Salazar and Corcoran (ml/min) 
Male :  {(1 37 - age) * [(0 .285 * BW) + (12 .1 * Ht * Ht)] }/(51 * screat) 
Female: {(146 - age) * [(0 .287 * BW) + (9 .74 * Ht * Ht)] }/(60 * screat) 
Walser (ml/min/3 m2) 
Male:  7,570/pcreat - (0 .1 03 * age) + (0.096 * BW) - 6 .66 
Female: 6,050/pcreat - (0 .08 * age) + (0.08 * BW) - 4.81  
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Agarwal and N icar (mL/min/1 .73 m2} 
Male: [(1 63 .95 - age) * BW * 1 .057]/pcreat 
Female: [(1 90 .43 - age) * BW * 0.707]/pcreat 
Gates (mL/min/1 .73 m2} 
Male: [89 .4 + (55-age) * (0.005 * 89.4)]/screat 1 . 2  
Female: [60 + (56-age) * (0.005 * 60)]/screat 1 .2 
Jelliffe 1 (mL/min/1 .73 m2} 
Male: (1 00/screat) - 1 2  
Female: (80/screat) - 7 
Jelliffe 2 (mL/min/1 .73 m2} 
Male: {98 - [1 6 * [(age - 20)/20] ] }/ screat 
Female: correction factor 0 .85 
Simplified MDRD (Levey et al} (mL/min/1 .73 m2} 
Male: 1 86 * screat - 1 .1 54 * age - 0 .203 
Female: correction factor 0 .742 
Nguyen (mL/min/1 .73 m2} 
21 8.1  - 0.91 6 * age - 0.635 * pcreat 
Toto (mL/min/1 .73 m2} 
Male: -0 .30 * (age - 52) + (9, 282/pcreat) + BW - 86 
Female: -0 .29 * (age - 52) + (7,780/pcreat) - 0.77 * (BM I  - 30) 
Rule (mL/min/1 .73 m2) 
Male: exp (1 .91 1 + 5249/screat - 2 1 14/screat2 - 0.00686 * age) 
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Abstract 
Background. Weight  excess is associated with increased renal risk. Data in overt 
obesity suggest  a role for altered renal hemodynamics. Whether body mass index 
( B M I) is also relevant to renal function in non-obese subjects is unknown . 
Methods and results. We studied the relation between B M I  and renal hemodynamics 
in 102 healthy, non-obese ( B M l<30 kg/m2) subjects (59 males, 43 females, mean age 
39 (18-69) years) in a post-hoc analysis of subjects evaluated as prospective kidney 
donors or as healthy volunteers in renal hemodynamic studies. 
Mean (±SD) B M I  was 24 .0±2 .8 kg/m2 , MAP 93±11 mmHg ,  g lomerular filtration rate 
(GFR, iothalamate clearance) 111 ±19 ml/min/1 .73m2 , effective renal plasma flow (ERPF, 
hippuran clearance) 458±108 ml/min/1.73m2 , FF (GFR/ERPF) 0 .25±0 .04 . On univariate 
analysis, B M I  correlated negatively with ERPF/1 .73m2 body surface area ( BSA) (r=-0 .46; 
p<0.001), GFR/1 .73m2 BSA (r=-0.24, p=0 .013) and positively with FF (r=0.45, p<0 .001), 
and age (r=0 .47, p<0.001) . On multivariate analysis both B M I  and age were independent 
predictors of ERPF/1.73m2 BSA (negative) and FF (positive, all p<0 .05). Age was the 
only predictor of GFR/1 .73m2 BSA (negative). Analyzed for renal function indexed for 
height ( h), B M I  correlated negatively with ERPF/h (r= -0 .274, p=0.005), but not with 
GFR/h (r=0 .13 , p=0 .899). On multivariate analysis both B M I  (positive) and age 
(negative) were independent predictors tor GFR/h (both p<0.001). Age was the only 
predictor for ERPF/h (negative). Predictors for FF ( B M I  and age, both positive) were by 
definition unaltered. 
Conclusions. The impact of B M I  on renal function is not limited to overt obesity, as in 
subjects with B M l<30 kg/m2 a higher B M I  is associated with a higher FF, that is , a 
higher GFR relative to ERPF. This suggests an altered afferent/efferent balance and 
higher g lomerular pressure ( i .e . ,  a potentially unfavorable renal hemodynamic profile) 
that may confer enhanced renal susceptibility when other factors, such as hypertension 
or diabetes are superimposed. 
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Introduction 
Obesity is increasingly recognized as a risk factor for renal function loss in several 
conditions such as after unilateral nephrectomy (1), in lgA nephritis (2) and in renal 
transplant recipients (3-6), although not all studies are equivocal. The mechanism 
underlying the increased renal risk of obesity is only partly characterized. It may be 
related to the concomitant cardiovascular and renal risk factors associated with obesity, 
such as hypertension and diabetes mellitus (7-12). In line with this assumption, altered 
renal hemodynamics have been implicated, as hyperfiltration - attributed to impaired 
glucose tolerance - is reported in obese subjects (7;9; 13). However, experimental and 
clinical studies suggested an increased renal risk in obese subjects without overt 
comorbidity as well (1 ;14-16). 
Weight excess is a continuous trait, and on a population basis, moderate weight excess 
has a much higher prevalence than overt obesity [body mass index (BMl)>30 kg/m2] .  
Data in renal transplant recipients suggest that the impact of BMI on long-term renal 
risk is not limited to subjects with overt obesity (5), but the relationship between BMI 
and renal hemodynamics in subjects in the non-obese range has not been well 
characterized. Therefore, in the present study we investigated the relationship between 
BMI and renal hemodynamics in non-obese subjects, in a post-hoc analysis of data 
obtained in healthy subjects evaluated as prospective kidney donors or as healthy 
volunteers in renal hemodynamic studies. 
Methods 
Patients 
The study group consisted of 102 healthy non-obese subjects [59 males, 43 females, 
mean age 39 (18-69) years] in whom renal hemodynamic measurements had been 
performed in our department. The subjects were either healthy subjects [n=61, male/ 
female ratio 27/34, mean age 47 (21-69) years] screened for kidney donation or healthy 
subjects [n=41, male/female ratio 32/9, mean age 24 (18-46) years] previously studied 
in experimental protocols including renal hemodynamic measurements as reported 
previously [(17;18) and unpublished data] . The healthy volunteers were studied during 
a standardized liberal (200 mmol Na+/day) sodium intake and prospective kidney 
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donors on an unrestricted sodium intake. Exclusion criteria for the present analysis 
were: hypertension (defined as repeated seated blood pressure>140/90 mmHg), 
diabetes mellitus (defined as fasting blood glucose>6.7 mmol/L and/or 2-hour 
postglucose concentration>11.1 mmol/L) and obesity (defined as BMl>30 kg/m2). 
Prospective kidney donors declared unfit, for whatever reason, to donate a kidney were 
excluded as well. 
Renal hemodynamic measurements 
Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were measured 
by constant infusion of radiolabelled tracers, 125 I-iothalamate and 131 I-hippurate, 
respectively, the subjects being in a quiet room, in the semi-supine position. After 
drawing a blank blood sample, a priming solution containing 0.04 ml/kg body weight 
of the infusion solution (0.04 MBq of 125I-iothalamate and 0.03 MBq of 131 I-hippurate) 
plus an extra of 0.06 MBq of 125 I-iothalamate was given at 08.00 hours, followed by 
infusion at 12 ml/h. In order to attain stable plasma concentrations of both tracers, a 
2-h stabilization period followed, after which baseline measurements started at 10.00 
hours. The clearances were calculated as (UxV)/P and (lxV)/P, respectively. UxV 
represents the urinary excretion of the tracer, lxV represents the infusion rate of the 
tracer and P represents the tracer value in plasma at the end of each clearance period. 
This method corrects for incomplete bladder emptying and dead space, by multiplying 
the urinary clearance of 125 I-iothalamate with the ratio of the plasma and urinary 
clearance of 131 I-hippurate (19;20). The filtration fraction (FF) was calculated as the ratio 
of GFR and ERPF and expressed as percentage. Renal vascular resistance (RVR) was 
calculated as mean arterial pressure (MAP) divided by ERPF. Blood pressure was 
measured noninvasively during the renal function measurements by sphygmomanometer. 
MAP was calculated as diastolic pressure plus one third of pulse pressure. Fat-free 
mass was estimated as described by Garrow (21 )  and Salazar (22) as: [weight x (1-A)] 
+ [B x height2] ,  with A being 0.715 and 0.713, and B being 12.1 and 9.74 for males and 
females, respectively. Fat mass was calculated as total body weight minus fat-free 
mass. 
Data analysis 
To comply with common practice in the literature, data on renal hemodynamic 
parameters were indexed per 1.73m2 body surface area (BSA). However, BSA as such 
is correlated with BMI. As this could induce bias when analyzing for the relationship 
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between renal parameters/1.73m2 and B M I, we also indexed the renal hemodynamic 
parameters for height (14;23). Data are g iven for both separately. 
Data are presented as mean±standard deviation. Associations were analyzed by 
univariate regression analysis ( Pearson). In addition, multilinear regression analys is 
was applied with B M I, age and MAP as independent variables entered into the 
regression equation and renal hemodynamic parameters (GFR, ERPF, FF and RVR, 
respectively) as dependent variables . Finally, to test whether the relationship between 
B M I  and renal hemodynamic parameters were biased by gender differences, or by 
selection bias due to differences in recruitment source (i .e. ,  healthy volunteer or 
prospective kidney donor), we also analyzed our data by general linear modeling ,  
including gender and recruitment source as  fixed factors in the analys is. 
Statistical computations were performed using SPSS, version 10.0 software (SPSS Inc. ,  
Chicago, IL, USA). A p-value less than 0.05 was considered statistically significant. 
Results 
Patient characteristics are presented in Table 1. All subjects had normal renal function. 
Thirty-eight subjects were overweight, defined as a B Ml>25 kg/m2 • B M I  was higher in 
older patients, as apparent from a positive correlation between age and B M I  (r=0.47, 
p<0.001). 
Figure 1 shows the univariate correlations between B M I  and renal hemodynamics 
indexed for BSA ( left panels) and height (right panels), respectively. B M I  correlated 
negatively with the BSA-indexed values of ERPF (r=-0 .46, p<0.001) and GFR (r= -0.24, 
p=0.013) and posi tively with FF (r=0.45, p<0.001, Fig. 2) and RVR (r=0.54, p<0.001) 
(data not shown). Univariate analysis for height-indexed renal hemodynamics showed 
that B M I  correlated negatively with ERPF/h (r= -0.274, p=0.005), but not with GFR/h 
(r=0.13, p=0.89). The correlation with FF was similar, by defin ition . In accordance with 
the correlation between BM I  and FF, fat mass also correlated positively with FF (r=0.45, 
p<0.001, Fig . 3). Fat-free mass correlated positively with uncorrected GFR (r=0.48, 
p<0.001) - but not with BSA-corrected or height-corrected GFR. No correlation was 
present between fat-free mass and B M I  (r=0.01, NS). 
Data on multivariate analysis are given in Table 2. As to the BSA-indexed renal 
parameters, both B M I  and age independently predicted ERPF (negatively), FF 





Age (years) 39±14 
Weight (kg) 75± 1 1  
Fat-free mass (kg) 57±9 
Fat mass (kg) 1 9 ±6 
Length (m) 1 .77±0. 10  
BM I  (kg/m2) 24 .0±2.8 
MAP (mmHg) 93± 1 1  
G FR/BSA (ml/min/1 .73 m2) 1 1 1 ±1 9  
ERPF/BSA (ml/min/1 .73 m2) 458±1 08 
FF 0 .25±0.04 
RVR/BSA (mmHg*1 .73/ml/min) 0 .22±0.06 
G FR/height (ml/min/m) 69±12  
ERPF/height (ml/minim) 286±67 
RVR/he ight (mmHg*m/ml/min) 0 .35±0.1 0 
Abbreviations are: BM I ,  body mass index : ;  MAP, mean arterial pressure; GFR, glomerular filtration rate; BSA, 
body surface area; ERPF, effective renal plasma flow; RVR, renal vascular resistance; FF, filtration fraction. 
Data are mean ± SE. 
GFR (r2= 0.27) ERPF (r2=0.51 ) FF (r2=0.30) RVR (r2=0 .70) 
B p B p B p B p 
BMI  -0 .0 12  0 .905 -0.1 74 0 .033 0 .267 0.007 0 . 16 1  0 .01 3 
MAP 0.069 0.459 0.058 0 .447 0.021 0 .81 6 0 .374 <0 .001 
Age -0 .553 <0.001 -0.649 <0 .001 0 .382 <0.001 0 . 532 <0 .001 
See Table 1 for abbreviations. BMI ,  MAP and age are entered in the model as independent variables, for GFR, 
ERPF, FF and RVR as dependent variables. R-square for the respective models for GFR, ERPF, FF and RVR 
is given in the upper l ine. Beta-values (standard coefficient b) and P-values are given for each independent 
variable separately. 
was not a predictor of renal hemodynamics. Multivariate data for the height-indexed 
renal parameters are given in Table 3. In this analysis age was the only predictor for 
ERPF and RV R (for both negative). Both BMI (positive) and age (negative) were 
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GFR (r2=0.31 )  ERPF (r2=0.48) FF (r2=0.30) RVR (r2=0.68) 
B p B p B p B p 
BMI  0.292 0.003 0.049 0.558 0 .267 0.007 -0 .009 0.893 
MAP 0.073 0.422 0.060 0.449 0.021 0 .81 6 0.399 <0.001 
Age -0.656 <0 .001 -0.740 <0.001 0.382 <0.001 0.608 <0.001 
See Table 1 for abbreviations. BMI ,  MAP and age are entered in the model as independent variables, for G FR, 
ERPF, FF and RVR as dependent variables. R-square for the respective models for GFR, ERPF, FF and RVR 
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Multivariate relationship between glomerular f i l tration rate (GFR) indexed for height ,  age and body mass 
index (BM I). The impact of BMI is  visual ized by presenting the data-points according to a breakup for BMI  
below or above the  median BMI  o f  th i s  population (median BMI :  23 .8  kg/m2) - demonstrating a steeper 
slope between GFR/h and age for subjects with BMI above the median. 
independent predictors for G FR/h as i l l ustrated in f igure 4 .  P red ictors for FF (BM I  and 
age,  both positive) were by defin ition s im i lar to those for the BSA-indexed values .  To 
test whether gender or recruitment source affected the relation ship between B M I  and 
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renal hemodynamics ,  general l inear model ing was performed with gender, and 
recruitment source included as factors in the analys is .  Whereas th is  confi rmed the 
s ignif icant impact of BMI (r2 of the model pred icti ng FF: 0 .370, p<0 .001 ) no s ign if icant 
effect of gender or recruitment source could be detected .  
Discussion 
In this study we found that a h igher BMI is  associated with a h igher  FF  in healthy 
non-o bese subjects , suggestin g  an effect of BM I  on afferent/efferent vasomotor 
balance. Thus ,  the unfavorable effects of excess weight on renal hemodynamics are 
not l im ited to overt obes ity. 
To compare renal hemodynamics between d ifferent ind ividuals with d ifferent body size , 
renal funct ion data are usually indexed for BSA. However, th is approach is challenged 
by studies showing that renal function correlates with he ight rather  than BSA i n  obese 
subjects (1 4 ;23). For our purpose ,  moreover, it i s  re levant to realize that weight gain in 
a subject of a given body size results in  a r ise in  BSA as well as B M I .  Thus, BMI and 
BSA are strongly correlated .  Obviously, this wi ll b ias any analys is  of the re lat ionship 
between BSA-indexed renal parameters and BMI towards a negat ive association .  
Therefore, we a lso performed our  analysis on he ight- indexed renal funct ion data. When 
indexed for  BSA, both GFR and ERPF were negatively correlated to BMI ,  but  for GFR 
th is associat ion was ann ih i lated by i ndexing for  he ight .  Our fi nd ing ,  however, that FF is  
h igher in  subjects wi th  a h igher  BM I  is  not dependent on the way renal funct ion is 
indexed , and thus stands out as a robust fi nd ing not affected by assumptions o n  the 
validity of index ing .  
Ag ing has been shown to be associated with a decl i ne  in  rena l  function in  healthy 
subjects (24) , although comorbid ity has been argued to be more important (25) .  In our 
study population a h igher  age was associated with a h igher  BM I .  Thus ,  the association 
between B M I  and renal hemodynamics observed here m ight be an age-related artifact . 
Therefore, we performed mu ltivariate analys is  - inc lud ing age as well as B M I .  This 
revealed that age was indeed the best predictor of renal hemodynamics ,  i rrespective of 
how renal function was indexed , with lower GFR and ERPF, and higher FF in  o lder 
pat ients . Neverthe less ,  B M I  remained an independent positive pred ictor for FF. 
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The independent predictive value of age and BMI for GFR/height could suggest that the 
alleged age-related decline in renal function will be more readily apparent in subjects 
with a higher BMI. However, our cross-sectional data set does not allow support for 
such a conclusion, and longitudinal data would be needed to that purpose. Moreover, 
in our cross-sectional data set the steeper slope between age and GFR/height in the 
subjects with higher BMI was due to a higher GFR in younger subjects rather than to a 
lower GFR in the older subjects. 
So far, no other studies reported on the impact of BMI on renal hemodynamics in 
subjects without overt obesity. Most studies on BMI compare lean and (morbidly) 
obese subjects with obesity defined according to varying cut-off levels. Our observation 
of a linear relationship between FF and BMI without an apparent cut-off or threshold 
justifies our approach of analyzing BMI as a continuous trait. The cut-off level of 30 kg/m2 
that we used to exclude overt obesity is in accordance with the National Health and 
Nutrition Examination Survey (26). 
Most studies report that GFR is elevated in obesity. Ribstein et al (9) found that height­
indexed GFR was approximately 10% higher in 20 obese normotensive subjects (mean 
BMI of 33.2) than in lean subjects (mean BMI of 22.4). Chagnac et al (27) reported 
elevated GFR (not indexed) in severe obesity (BMl>38). An older study on the 
relationship between body composition and renal function in obesity reported a 
positive correlation between creatinine clearance and fat-free body mass; as fat-free 
body mass was elevated in obese subjects this accounted for a higher creatinine 
clearance in morbid obesity (22). The higher GFR in obesity in those studies is in line 
with the positive predictive value of BMI for GFR in our multivariate analysis. Anastasio 
et al (14), however, reported no difference in height-indexed GFR between severely 
overweight (mean BMI of 46.8) normotensive men and non-obese (BMI of 25.6) control 
subjects. 
Data on ERPF are somewhat more variable between studies. Anastasio et al reported 
a normal height-indexed ERPF in normotensive obese subjects (14). Other studies, 
however, found an elevated (height-indexed) ERPF in normotensive as well as 
hypertensive obese subjects (10). Porter et al found a higher renal perfusion (per kidney 
volume) in mildly obese, normotensive subjects (15) during severe sodium restriction, 
but not during liberal sodium intake. Scaglione et al (8), by contrast, reported a lower 
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(non-indexed) ERPF in normotensive subjects with central obesity. Finally, Schmieder 
et al (23) reported that height-indexed ERPF was not affected by obesity in a mixed 
population of hypertensive and normotensive subjects - whereas BSA-indexed ERPF 
was lower in obese subjects. The absence of impact of BMI on height-indexed ERPF, 
as well as the negative predictive value of age for ERPF in the latter study, is well in line 
with our multivariate data. 
Differences in indexing may explain some of the above discrepancies, but data on the 
relationship between FF and BMI are not uniform either, indicating that the discrepancies 
cannot fully be attributed to differences in indexing. Some authors, in line with our data, 
report an elevated FF in obesity (27). Ribstein et al, however, found a higher FF in 
obesity in hypertensive, but not in normotensive subjects (9), suggesting interaction 
between obesity and hypertension. This is in line with data from Scaglione et al (8) who 
found an elevated FF in (central) obesity only in hypertensive, but not in normotensive 
subjects with central or peripheral obesity. The discrepancies suggest impact of 
comorbidity, such as hypertension (8;9) and insulin resistance (27), but differences in 
severity of obesity, age, or sodium intake may also have affected the impact of obesity 
on FF. 
Several limitations of our study should be considered. First, possible selection bias. We 
included only healthy subjects, but our population was not homogeneous as to 
recruitment source, with prospective kidney donors being older, and with over-repre­
sentation of younger males among the healthy volunteers. Moreover, being selected for 
being healthy at middleage (i.e., donors) may select individuals that represent the 
healthiest part of their age-cohort - which is probably less so for healthy subjects in 
their twenties. Thus, although we could not detect a significant effect of recruitment 
source, bias by the heterogeneity in this population cannot be excluded, and it would 
be relevant to test whether our findings also hold in more homogenous populations. 
Second, our study was not suitable to identify mechanisms underlying the relationship 
between BM! and renal hemodynamics - by its post-hoc nature, and by lack of data on 
possibly relevant factors such as body fat distribution (28), insulin sensitivity, or insulin 
levels, activity of the sympathetic nervous system (13;29;30) the renin-angiotensin 
system ( RAS) (29;31-33), lipids, and leptin levels. Data in the literature suggest 
involvement of these factors in renal hemodynamic changes in obesity, and by 




namics in non-obese subjects. Our study did not include formal measurements of body 
composition. However, as the latter may be relevant as well (22), we estimated fat mass 
and fat-free mass from anthropomorphic data, and found a significant positive 
correlation between fat mass and FF. In accordance with data of Salazar et al in a small 
number of normal and morbidly obese subjects, GFR (uncorrected) correlated 
positively with fat-free mass. However, in our non-obese population, a higher BMI was 
not associated with a higher fat-free mass - so the latter does not appear to account 
for the impact of BMI on renal function that we observed. 
A role for insulin resistance in obesity-associated changes in renal function is suggested 
by the epidemiological association between waist-hip ratio and renal function (28), as 
well as by the association between obesity-associated increases in GFR (and FF) and 
the degree of insulin resistance (34). The latter association was blunted by liberal 
sodium intake (33), which is in line with data from Porter et al, who found an obesity­
associated increase in renal perfusion during low sodium only. In our study sodium 
intake was unrestricted in the majority of the subjects (kidney donors), and standardi­
zed at a liberal level in the others. Thus, in our study sodium status, if anything, can be 
expected to have blunted the relationship between BMI and renal hemodynamics. The 
impact of sodium intake was suggested to imply a role for the RAS (1 5), supported by 
the finding that the renal hemodynamic response to RAS-blockade is proportional to 
BMI in type I I  d iabetes (35). The mechanism of the link between insulin resistance and 
renal hemodynamic alterations in obesity has not been elucidated yet. Hyperinsulinemia 
might be involved , but experimental hyperinsulinemia does not lead to elevated FF, 
neither in acute nor in chronic experiments (1 2;36;37), which is at variance with this 
assumption. Recent data suggest that leptin may be relevant. Serum leptin levels 
correlate strongly with BMI (38), and leptin stimulates sympathetic nervous activity and 
reactive oxygen species (39). However, so far, in clinical studies, leptin levels could not 
be identified as a renal risk factor (40;41). 
Animal data on the glomerular microcirculation in obesity indicate changes resembling 
those after renal ablation, with glomerular hypertension and hyperfil tration. In obese 
Zucker rats, a genetic model of obesity, GFR was either normal (42;43) elevated (44;45), 
with either normal (45) or elevated glomerular capillary pressure (43). In this model 
elevated GFR appears to precede glomerulosclerosis, without, however, being a 
prerequisite for renal structural damage (42;45). An impaired myogenic afferent 
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vasoconstriction may be involved in the altered glomerular hemodynamics (46). Food 
restriction reduces the elevated GFR (40), demonstrating the contribution of a functional 
component, alongside structural abnormalities. However, the mechanisms of the renal 
changes in genetically obese models appear to be different from those in man, for 
instance, regarding the role of the renin-angiotensin system and the sympathetic 
nervous system (29;43). Obesity induced by over-feeding in dogs and rabbits (47) may 
more closely mimic the human condition (29). In dogs feeding-induced obesity leads 
to a considerably elevated GFR and renal plasma flow already after a few weeks, 
coinciding with structural changes such as mesangial matrix expansion and cell 
proliferation (7;29), likely precursors of glomerulosclerosis. The elevated GFR has been 
hypothesized to render the kidney susceptible to progressive glomerulosclerosis, 
especially when hyperlipidemia, hyperglycemia, or hypertension are simultaneously 
present. Whether the mechanisms observed in experimental obesity-associated renal 
damage also apply to our observations on BMI and renal hemodynamics in non-obese 
subjects, however, remains to be investigated. 
What is the clinical impact of our findings? It is well established that the overall health 
risks of excess weight are not limited to overt obesity (48). As to renal risk, data in renal 
transplant recipients showed that the renal risk of excess weight is not limited to overt 
obesity either (5). In line with this, our data indicate that even moderate overweight is 
associated with an unfavorable renal hemodynamic pattern, i.e., an elevated FF. This 
may render the kidney susceptible to damage by other renal risk factors, such as 
hypertension - as supported by the data of Ribstein et al (9). As moderate overweight 
has a much higher prevalence than overt obesity, the population-attributable risk of 
overweight for renal damage therefore deserves proper consideration. 
Conclusion 
The impact of BMI on renal hemodynamics is not limited to overt obesity, as also in 
subjects with BMl<30 kg/m2 a higher BMI is associated with higher GFR relative to 
ERPF, suggesting altered afferent/efferent balance and a higher glomerular pressure. 
This potentially unfavorable renal hemodynamic profile may result in enhanced renal 
susceptibility when other factors, such as hypertension are superimposed. Prospective 
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CHAPTER 4 
Abstract 
Background. Obesity is a risk factor for renal graft loss. Higher body mass index (BM I)  
in native kidneys is associated with glomerular hyperfiltration. Whether higher BM I in  
renal transplants is associated with hyperfiltration is unknown. We investigated the 
impact of BMI on renal hemodynamics 1 year post-transplant. 
Methods and results. We analyzed glomerular filtration rate (GFR, 125 1-iothalamate) 
and effective renal plasma flow (ERPF, 131 1-hippurate) in 838 kidney transplants. Data 
were analyzed for all patients and for the subpopulation without diabetes. Long-term 
impact of BMI and renal hemodynamics were explored by Cox-regression. With higher 
BM I GFR and fi ltration fraction (FF) increased significantly. Multivariate analysis 
supported impact of BMI on GFR (adjusted r2 of the model 0.275) and FF (adjusted r2 
of the model 0.158). This association was not explained by diabetes mellitus. On Cox­
regression analysis, lower GFR and higher FF were independent determinants of overall 
graft loss and graft loss by patient mortality. Lower GFR and higher BM I were 
determinants of death-censored graft loss, with borderline contribution of higher FF. 
Conclusions. In renal transplants higher BM I is independently associated with higher 
GFR and FF one year post-transplant, suggesting glomerular hyperfiltration with altered 
afferent-efferent balance. Mechanisms underlying the long-term prognostic impact of 
hyperfiltration deserve further exploration. 
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Introduction 
Obesity is common after renal transplantation. Several studies showed that obesity is 
a risk factor for impaired renal graft function (1) and graft loss (2-5). In native kidneys 
obesity is a risk factor for renal function loss as well (6;7). Several mechanisms may be 
involved in this association. First, obesity is often associated with other renal risk 
factors, such as hypertension and diabetes mellitus, but independent effects of obesity 
are also likely. In particular, renal hemodynamic factors have been suggested to play a 
role, as obesity and even mild overweight are associated with glomerular hyperfiltration, 
apparent from elevated glomerular filtration rate (GFR) and/or filtration fraction (FF) ,  
even when blood pressure and glucose tolerance are normal (8;9). 
In renal transplant recipients the mechanisms of the increased renal risk are 
incompletely characterized, but it has been suggested that hypertension, diabetes and 
vascular disease may be involved. Whether in renal transplants body mass index (BMI) 
affects renal hemodynamics is unknown (10). In renal transplants multiple factors, such 
as cyclosporin use, the single kidney state, and presence of intrinsic renal damage all 
may affect renal hemodynamics, precluding extrapolation from data in native kidneys 
to the transplant population. In the present study we therefore investigated whether BMI 
was a determinant of renal hemodynamics in renal transplant recipients. We studied 
data obtained at routine evaluation one year after transplantation from 838 consecutive 
patients transplanted between 1984 and 2002 in our center in a cross-sectional 
analysis. This analysis showed BMI to be an independent determinant of renal 
hemodynamics. In an exploratory analysis, subsequently, we tested the long-term 
prognostic impact of BMI and renal hemodynamics, respectively, on graft survival. 
Methods 
Patients 
The study group consisted of 838 renal transplant recipients, 486 males and 352 
females, transplanted between 1984 and 2002, with follow-up data being included until 
January 2004 (mean age at transplantation 45±13 years) in whom renal hemodynamic 
measurements had been routinely performed 1 year after transplantation. Of these 
patients 760 had received a transplant from a deceased donor and 78 a transplant from 
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a living donor. Mean donor age was 39±16 years , with 472 males and 366 females . 
Obesity was defined as a B Ml>30 kg/m2 . B M I  of the recipient was not considered in 
allocation of donor organs from male or large donors . Diabetes mellitus was found in 
135 patients (defined as having at least two values of non-fasting serum glucose>11.1 
mmol/L and/or use of glucose lowering medication). 
Triple immunosuppressive treatment consisted of cyclosporin A (CsA), azathioprine 
and steroids .  Following the introduction of mycophenolate mofetil (MMF) in May 1997 
patients were treated with CsA, M MF and steroids .  CsA was started early postoperatively, 
and doses were adjusted to trough levels of 200-250 ng/ml for the first 3 months. 
Thereafter doses were s lowly tapered to trough levels of 150-200 ng/ml during 
follow-up. Prednisolone dose of 20 mg/day was tapered over 8 weeks to a maintenance 
dose of 1 O mg/day. MMF was given in a stable dose of 1 g twice daily, starting at day one. 
Antihypertensive treatment was given in 605 patients, of whom 83 received RAAS­
blockade (ACE inhibitor or angiotensin receptor blocker (ARB)). RAAS-blocker use was 
equally d istributed among the obese and non-obese patients (11.1% versus 9.7%, ns). 
Methods 
Renal hemodynamic measurements 
Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were measured 
by constant infusion of 125 I-iothalamate and 1 31 I-hippurate, as described by Danker et al 
(11) and Apperloo et al (12). During the measurements the subjects were in a quiet room 
in the semi-supine position . After drawing a blank blood sample, a priming solution 
containing 0.04 ml/kg body weight of the infusion solution (0.04 M Bq of 1 25I-iothalamate 
and 0.03 M B q  of 131 I-hippurate) plus an extra of 0 .06 M Bq of 125I-iothalamate was given 
at 08.00 a.m., followed by continuous infusion at 12 ml/h .  In order to attain stable 
plasma concentrations of both tracers , a 2 h stabilization period followed, after which 
baseline measurements started at 10.00 a.m. The clearance was calculated as (UxV)/P 
and ( lxV)/P, respectively. UxV represents the urinary excretion of the tracer, lxV 
represents the infusion rate of the tracer and P represents the tracer value in plasma at 
the end of each clearance period . Correction for incomplete bladder emptying and 
dead space was performed by multiplying the urinary clearance of 125 I-iothalamate with 
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the ratio of the plasma and urinary clearance of 131I-hippurate. As the association 
between BMI and body surface area induces bias in BSA-normalized data, we refrained 
from BSA-normalization, and data on GFR and ERPF are given in ml/min. In addition 
we analyzed the data normalized for height. The filtration fraction (FF )  was calculated 
as the ratio of GFR and ERPF, and expressed as a percentage. Mean arterial pressure 
(MAP) was calculated as diastolic pressure plus one third of the pulse pressure. 
Statistical analysis 
The impact of BMI on renal hemodynamics at year one was assessed by univariate 
analysis and by multivariate analysis. For the univariate analysis, a break-up was made 
by tertiles of BMI, and BMl-groups were compared by ANOVA followed by post-hoc 
analysis (Tukey test). Multivariate analysis was conducted in the patients without overt 
diabetes mellitus - by using multilinear regression - and included BMI, MAP, age 
(recipient and donor), sex (recipient and donor), ischemia times, H LA mismatches, 
RAAS-blockade and proteinuria as independent variables. GFR, ERPF and FF were 
included as dependent variables. To explore the impact of renal hemodynamics and 
BMI at 1 year after transplantation on graft survival, Cox regression analysis was 
performed for overall graft loss, death censored graft loss, and graft loss by patient 
mortality as dependent variables. 
Statistical computations were performed using SPSS, version 12.0 (SPSS Inc, Chicago, 
IL, USA). A p-value less than 0.05 was considered statistically significant. 
Results 
Table 1a shows the patient characteristics for the whole population (n=838) and for the 
subpopulation without overt diabetes mellitus (n=703). Mean BMI for the whole 
population was 26±4 kg/m2, in 108 patients (13%) BMI was h igher than 30 kg/m2. Mean 
BMI for the subpopulation without diabetes mellitus was 25±4 kg/m2, with 80 subjects 
(11%) having a BMI higher than 30 kg/m2 • Table 1b shows the patient characteristics -
including the presence of diabetes mellitus - for the whole population, for tertiles of 
BMI. By definition, BMI was different between the tertiles. Additionally, recipient age, 
second warm ischemia time and proportion of subjects with diabetes were significantly 
h igher in the h igher BMI tertiles. 
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Whole population (n=838) Subpopulation without 
diabetes mellitus (n=703) 
Recipient sex (male/female) 486/352 41 3/290 
Recipient age (years) 45±13  (1 4-77) 44±13  (1 4-77) 
Recipient BMI (kg/m2) 26±4 (1 6-47) 25±4 (1 6-45) 
Donor sex (male/female} 472/366 401/302 
Donor age (years) 39± 1 6  (0-71 )  44± 1 5  (2-71 ) 
GFR (ml/min) 53±1 8 (7-1 1 5) 53±1 8 (7-1 1 5) 
ERPF (ml/min) 21 3±68 (21 -496) 2 13±67 (21 -496) 
FF (%) 25± 5  (8-50) 25±5 (8-50) 
MAP (mmHg) 1 08±12  (73-1 67) 1 08±12  (73-1 47) 
WI t ime 1 (minutes) 1 . 2±7.3 (0-80) 1 .3± 7.9 (0-80) 
Cl t ime (hours) 22 .0±9.2 (0-44) 22 .2±9.3 (2-44) 
WI t ime 2 (minutes) 38.1 ±1 1 .4 (1 5-83) 37. 8±1 1 .2 (1 5-83) 
HLA MM AB 1 . 2±1 .0 (0-4) 1 . 2±1 .0 (0-4) 
HLA MM DR 0 .3±0 .5  (0-2) 0 .4±0 .5 (0-2) 
RAAS-blockade (n) 83 70 
Uprot (g/24 h) 0 .5±1 .1 (0-1 8 .9) 0 .5±1 .1 (0-1 8 .9) 
Table showing patient characteristics, mean±SD (range) for the whole population and the subpopulation 
without diabetes mell itus. 
Univariate data are given in Figure 1, showing mean values of G F R, ERPF, FF and MAP 
by tertile of BMI. GFR was significantly higher with higher BMI (ANOVA p<0.001), with 
a significant difference between the highest and lowest tertile on post-hoc analysis. The 
same relationship was found for height-corrected GFR (data not shown). ERPF also 
increased per tertile, however the differences were not statistically significant. Identical 
findings were seen for height-corrected ERPF. Consequent to the values of GFR and 
ERPF, FF was significantly different for the BMI tertiles, with a higher FF at higher values 
of BMI (ANOVA p=0.006), with a significant difference between the highest and lowest 
tertile on post-hoc testing. BMI had no impact on MAP. 
The number of patients on RAAS-blockade (total n=83) was equally distributed over 
the tertiles. In all tertiles G F R  and FF were significantly lower (all p<0.001 )  in patients 
with RAAS-blockade than in those without, namely 39 ml/min versus 52 ml/min, 
45 ml/min versus 55 ml/min and 49 ml/min versus 57 ml/min for GFR, and 21% 
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BMI  1 (n = 279) BMI  2 (n=280) BMI 3 (n=279) p 
Recipient sex (male/female) 1 56/123 172/108 1 58/121 0.357 
Recipient age (years) 39±14 (1 4-77) 47±12 (19-71) 48±13 (17-71) <0.001 
Recipient BM I (kg/m2) 21 .7±1 .6  25.3±0.9 29.9±3.0 <0.001 
(15.8-23.7) (23.7-26.9) (26.9-46.6) 
Donor sex (male/female) 1 52/127 1 58/122 1 62/1 17  0.695 
Donor age (years) 38±1 6 (2-69) 39±16 (6-71) 39±1 5 (1 -71) 0.585 
WI t ime 1 (minutes) 1 . 2±6.9 (0-30) 1 . 2±6.8 (0-30) 1 .3±8.2(0-80) 0.71 1 
Cl time (hours) 22.1 ±9.8 (2-40) 22.1 ±8.7 (2-40) 22.8±9.0 (0-44) 0.651 
WI time 2 (minutes) 37.2±1 0.8 (1 6-65) 37.2±10.8 (15-70) 40.0±12.5 (1 5-83) 0.008 
HLA MM AB 1 .2±1 .0 (0-4) 1 .2±1 .0 (0-4) 1 .3±0.9 (0-4) 0.924 
HLA MM DR 0.4±0.5 (0-2) 0.4±0.5 (0-2) 0.3±0.5 (0-2) 0.430 
RAAS-blockade (n) 27 29 27 0.953 
Uprot (g/24 h) 0.5±1 .4 (0-1 8.9) 0.4±0.7 (0-8.2) 0.5±1 .1 (0-9.6) 0.381 
Diabetes mellitus (n) 31 35 69 <0.001 
Table showing patient characteristics, mean±SD (range) for the whole population for tert1 les of BMI .  
versus 25%, 24% versus 26% and 23% versus 26% for increasing tertiles of BMI for FF. 
Values for ERPF and MAP were similar in subjects with and without RAAS-blockade. 
To analyze whether the univariate data could be confounded by overrepresentation of 
patients with diabetes mellitus among those with the highest BMI, we conducted the 
same analysis after exclusion of the overtly d iabetic patients. For the 703 non-diabetic 
patients data are shown in Figure 2 (black bars left of the dashed lines), showing similar 
findings for GFR (ANOVA p=0.002), ERPF, FF (ANOVA p=0.007) and MAP as for the 
whole population. For comparison, the values of the subpopulation with d iabetes 
mellitus (n=135) are given as well (gray bars right of the dashed lines). Multivariate 
analysis (Table 2) was performed in the non-diabetic patients to see whether the effect 
of BMI on renal hemodynamics was independent of age (of recipient and donor), MAP, 
ischemia times, H LA mismatches and proteinuria. Indeed, BMI was independently 
associated with a higher GFR (p<0.001, r2 of the model 0.275), ERPF (p<0.001, r2 of 
the model 0.197) and FF (p=0.038, r2 of the model 0.158) 1 year after transplantation. 
Additional determinants for GFR were MAP, donor age, recipient sex, cold ischemia 
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Mean (±SD) values of G FR ,  ERPF, FF and MAP respectively, by tertile of BM I .  Bars show renal 
hemodynamics at 1 year after transplantation for the whole population (n =838). 
* indicates p<0.05 (ANOVA) 
donor and recipient age, donor and recipient sex, number of H LA-DR mismatches and 
cold ischemia time. For FF, additional determinants were MAP, recipient and donor age, 
donor sex, RAAS-blockade and proteinuria. Essentially similar results were obtained 
when data were analyzed for GFR/height (data not shown). 
To test whether the impact of BMI on renal hemodynamics was persistent over time, we 
also measured renal hemodynamics at 5 years after transplantation in the same 
patients, and analyzed by BMI tertile of year 1. At that time 112 grafts had been lost -
47 due to graft failure, and 65 as a result of patient mortality. Of the remaining 726 
patients, data on renal hemodynamics at year 5 were available in 545 patients in whom 
data had been obtained at year 1 as well. At year 5 numerical differences were present 
by increasing BMI tertile for GFR (51±18 ml/min versus 53±21 ml/min versus 
55±21 ml/min) and FF (23±5% versus 24±5% versus 24±5%), that did however not 
reach statistical significance. In a paired test between year 1 and 5, in the lower tertiles 
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Mean (±SD) of GFR, ERPF, FF and MAP respectively, by terti le of BMI  for the non-diabetic subjects (n=703, 
b lack bars left of the dashed l ines). For comparison,  data on GFR, ERPF, FF and MAP in the d iabetic 
subjects are shown as well (n=1 35, gray bars right of the dashed l ines). * indicates p<0.05 (AN OVA) 
of BMI GFR remained stable (51±15 ml/min versus 51±18 ml/min and 55±18 ml/min 
versus 53±21 ml/min for tertile 1 and 2 respectively), with a significantly lower FF at 
year 5 (25±4% versus 23±5% and 26±4% versus 24±5% for tertile 1 and 2 respectively, 
both p<0.001). For the highest tertile GFR was significantly lower at year 5 (59±18 ml/ 
min versus 55±21 ml/min, p=0.002), with a lower FF as well (26±4% versus 24±5%, 
p<0.001). Individual changes in renal hemodynamics between year 1 and 5 were not 
related to changes in BMI. 
Long-term impact of B M I  and renal hemodynamics on graft survival 
To explore the possible long-term impact of BMI and its renal hemodynamic correlates 
for graft survival Cox-regression analysis was performed for overall graft loss, 
death-censored graft loss, and graft loss by patient mortality, respectively. Dur ing the 
follow-up per iod overall graft loss amounted to 268/838 grafts, death-censored graft 
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G FR (r2=0.275) ERPF (r2= 0.1 97) FF (r2=0 .1 58) 
B p B p B p 
BMI  0.1 83 <0.001 0 . 137 <0 .001 0 .D78 0.038 
MAP -0.074 0.036 -0 . 145 <0 .001 0.1 1 9  0 .002 
Recipient age -0 .047 0.1 85 -0 .1 24 0 .001 0.1 33 <0 .001 
Donor age -0 .404 <0.001 -0 .302 <0.001 -0 .259 <0.001 
Recipient sex (male) 0.1 37 <0.001 0 . 135 <0 .001 0 .048 0.1 96 
Donor sex (male) 0.026 0.450 0.080 0 .027 -0.123 0.001 
WI time 1 -0 .053 0.120 -0.060 0.094 -0 .003 0.926 
Cl time -0 . 189 <0.001 -0 . 177 <0.001  -0 .052 0 .178 
WI time 2 0.01 0 0.772 0.006 0. 870 0 .01 0 0 .797 
HLA MM AB -0 .043 0 .221 -0 .01 1 0 .770 -0.059 0 . 12 1  
HLA MM DR -0 .056 0 . 125 -0 .090 0.020 0.051 0.1 99 
RAAS-blockade -0 . 1 41 <0.001 -0 .069 0 .059 -0.1 1 0  0.003 
Uprot -0 .1 34 <0.001 0 .020 0 .590 -0 .1 55 <0.001 
Table showing multivariate analysis of the determinants of renal hemodynamics in  the subjects without 
diabetes mellitus, n==703. 
Covariates Overall Death censored Graft loss by 
graft loss graft loss patient mortality 
Exp(B) p Exp(B) p Exp(B) p 
Age 1 ,033 0 ,000 0,977 0 ,007 1 ,062 0 ,000 
Recipient sex (male) 0,71 5 0 ,012  0 ,543 0,006 0,778 0,1 06 
BMI 1 ,024 0,1 97 1 ,081 0 ,003 1 ,002 0 ,924 
MAP 1 ,008 0,1 65 1 ,007 0 ,434 1 ,01 0 0 ,1 1 2  
Uprot 1 ,207 0,000 1 ,1 57 0 ,001  1 ,241 0,000 
GFR 0,969 0,000 0,948 0 ,000 0 ,975 0 ,000 
FF 1 ,031 0 ,040 1 ,045 0 ,053 1 ,046 0 ,01 1 
RAAS-blockade 1 ,038 0,866 1 , 376 0 ,3 1 1 0 ,893 0 ,705 
Table showing the long-term impact of body mass index and g lomerular hyperfiltration at one year after 
transplantation: Cox regression analysis model summary. 
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loss to 100/838 grafts, and graft loss by patient mortality to 168. The summary of the 
respective Cox-regression models is g iven in Table 3. It shows that the independent 
determinants of overall graft loss were a higher age, recipient sex, proteinuria, a lower 
GFR and a higher FF, whereas blood pressure, BMI and RAAS-blockade were not 
included in the model. For death-censored graft loss the independent determinants 
were a younger age, recipient sex, a higher BMI, proteinuria and a lower GFR, whereas 
a higher FF was of borderline significance. RAAS-blockade and blood pressure were 
not included in the model. Finally, independent determinants of graft loss by patient 
mortality were a higher age, proteinuria, a lower GFR and a higher FF, whereas blood 
pressure and recipient sex were of borderline significance and BMI and RAAS-blockade 
were not entered into the model. Inclusion of donor age and donor sex into the model 
did not improve the models, and these covariates did not reach significance (data not 
shown). 
As an increase in BMI after transplantation has been reported to be associated with 
graft loss, we finally tested whether an increase in BMI of more than 5% predicted graft 
loss. A comparable Cox regression analysis model was used (covariates: GFR ,  FF, 
increase in BMI more than 5%, blood pressure, recipient and donor age, donor sex and 
RAAS-blockade, and proteinuria). An increase in BMI of more than 5% in the first year 
after transplantation was observed in 663/838 patients. This increase, however, was not 
a predictor for graft loss. 
Discussion 
In this study, we showed that in renal transplant patients a higher BMI is independently 
associated with a higher GFR and FF, one year after transplantation. On multivariate 
analysis ERPF was determined by BMI as well. The impact of BMI on renal 
hemodynamics was not explained by the presence of overt diabetes. On long-term 
fol low-up, a higher FF was associated with the risk for overall graft loss, by an effect on 
patient mortality and a borderline effect on death-censored graft loss, whereas BMI 
was associated with death-censored graft loss but not patient mortality. 
We recently demonstrated a relationship between BMI and renal hemodynamics in a 
group of healthy subjects, with a higher GFR and FF in subjects with a higher BMI (9). 
77 
CHAPTER 4 
In the renal transplant population, however, many factors can influence overall renal 
hemodynamics and the afferent/efferent balance, such as nephrotoxic agents (eg 
calcineurin inhibitors), other drugs that affect renal hemodynamics such as RAAS­
blockers, viral infections, ischemic reperfusion injuries, acute rejection and the single 
kidney state. To overcome the potential confounding effects of acute events, we studied 
the patients one year after transplantation, in a stable condit ion and not in the 
immediate post-transplant period, in which the occurrence of these factors is more 
common. Our present data show that the impact of BMI is apparently sufficiently robust 
to be discernible despite the various other factors that affect renal hemodynamics in 
renal transplant recipients. 
A high BMI has been shown to be a risk factor for long-term renal graft loss (2-4). 
The risk conferred by high BMI is assumed to be multifactorial, including diverse factors, 
such as hypertension, concomitant cardiovascular factors and diabetes mellitus. So far, 
no data were available on the renal hemodynamic effects of BMI in the adult transplant 
population. Our data, in particular the association between a higher BMI and a higher 
fi ltration fraction suggest that a higher BMI may be associated wi th a higher filtration 
pressure, which can be a factor contributing to long-term renal function loss in the graft. 
Indeed in our study BMI was an independent predictor of death-censored graft loss. 
This confirms the role of BMI as a renal risk factor in our population, as also supported 
by the longitudinal decrease in GFR between year 1 and 5 in the highest BMI tertile only. 
An independent effect of a higher FF on death-censored graft loss was found as well, 
albeit of borderline statistical signficance. Remarkably, however, a higher FF - along with 
well-established risk factors such as age, sex, GFR and proteinuria, was an independent 
predictor for graft loss by patient mortality and overall graft loss. 
The prognostic impact of FF for mortality is remarkable and to the best of our 
knowledge has not been described before. The mechanism underlying this association 
would be of interest, but our study does not allow the identification of such mechanisms. 
In non-transplant populations a higher FF was found to be associated with impaired 
cardiac function, and/or left ventricular hypertrophy (13-15), both risk factors for 
mortality. Prospective data including cardiac evaluation would be required to see 
whether underlying cardiac disease is involved in the predictive effect of FF for patient 
failure. Of note, graft loss by patient mortality considerably outnumbered death­
censored graft loss. Accordingly, the power of our study to identify the long-term renal 
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consequences of a higher FF, as assessed from death-censored graft loss, was 
reduced by the competing risk for graft failure by patient mortality. 
Several other, smaller, studies addressed renal function in association with obesity in 
renal transplant recipients - however only providing data on GFR or creatinine clearance 
and without assessment of ERPF and FF (10;16;17). In these studies no hyperfiltration 
was detected, but it was shown that obesity was associated with worse renal outcomes. 
An elegant study by Yamamoto et al (18) on paired cadaveric kidneys showed that 
recipient obesity was not a risk factor for delayed graft function (DGF) or acute rejection 
and did not lead to a lower 1-year graft survival. However, after a follow-up of 5 years 
recipient obesity was associated with a significantly decreased graft survival. Thus, the 
renal risk associated with recipient obesity in renal transplantation is apparently a 
long-term risk. Finally, one recent study drew attention to the impact of weight gain 
during the first year after transplantation as a risk factor for graft loss (19). Our data, 
however, could not confirm this association. 
Our study was not designed to unravel the mechanisms underlying the impact of body 
mass index on renal hemodynamics. The mechanisms may be related to concomitant 
cardiovascular and renal risk factors associated with obesity, such as diabetes mellitus 
and hypertension, with RAAS activity (20;21) and/or sympathetic activity (22;23) as 
relevant pathways. Also in obese, otherwise healthy subjects renal hemodynamics 
appear to be RAAS dependent (21). Our present data in transplant recipients allow 
several inferences on the effect of BMI on renal hemodynamics. First, they apparently 
occur in the single kidney setting, and accordingly, in a presumably denervated kidney. 
Second, it should be noted that it was recipient BMI that affected hemodynamics in the 
donor kidney, suggesting that the association between BMI and renal hemodynamics 
is due to factors exogenous to the kidney, such as circulating factors. It should be noted 
in this respect, however, that we did not have reliable data on donor BMI - so 
confounding by effects of donor BMI cannot completely be excluded. Finally, the 
association between BMI and renal hemodynamics in our study was not explained by 
presence of overt diabetes, but it should be noted that we cannot rule out an effect of 
impaired glucose tolerance. 
What could be the implications of our findings? Our results support the impact of both 
BMI and renal hyperfiltration, as apparent from FF, as independent risk factors for graft 
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loss. Obviously, long-term preservation of graft function requires a multifactorial 
approach, with control of hypertension, dyslipidemia and glycemic regulation. Our data 
seem to indicate that in transplant recipients with high BMI renal hemodynamics might 
provide a target for intervention. In this respect RAAS-blockade should be considered 
as a possible approach, as the renal hemodynamic profile associated with obesity is 
ameliorated by ACE inhibition in healthy subjects (21). In our study RAAS-blockade was 
associated with lower GFR and FF, suggesting that it ameliorates glomerular hyperfil­
tration in renal transplants. Whereas it could be argued that RAAS-blockade did not 
affect long-term outcome in our study, obviously our study was not designed or 
powered to this purpose. As to the specific renal risk (estimated from death-censored 
graft loss) it should be noted, that BMI exerted an effect that was independent of renal 
hemodynamics and blood pressure, and that may require specific additional 
interventions, for instance aimed at correction of weight excess. It would be attractive, 
furthermore, to investigate whether RAAS-blockade could reduce graft loss by patient 
mortality. The beneficial effects of RAAS-blockade in conditions characterized by 
excess neurohumoral activity, such as heart failure, are well-established (24) and it 
would be reasonable to speculate that the association between elevated FF and patient 
failure reflects excess neurohumoral activation, related to cardiac factors, weight 
excess or other. Prospectively controlled studies would be needed to identify the 
long-term protective effects of RAAS-blockade in renal transplant recipients. 
In conclusion, higher BMI induces glomerular hyperfiltration in renal transplant patients. 
This unfavorable hemodynamic profile is not explained by the presence of overt 
diabetes mellitus. A higher FF was associated with graft loss, predominantly by patient 
mortality, whereas BM I was only associated with death-censored graft loss. 
The mechanisms underlying the prognostic impact of an elevated FF in the transplant 
population deserve further exploration. 
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Renal functional reserve after 
l iving kidney donation is more 
reduced in  donors with higher 
body mass i ndex or older age 
Mieneke Rook, Renate J .  Bosma, Wil lem J .  van Son, H .  S 1jbrand Hofker, 




Background. Renal functional reserve could be relevant for maintenance of renal 
function after kidney donation . Older age and higher body mass index ( B M I) may be 
associated with reduced reserve capacity (RC). We therefore investigated RC in 178 
consecutive living kidney donors (39% male, age 48±11 years, B M I  25.5±4.1). RC was 
determined as the rise in glomerular filtration rate (GFR; 125 I-iothalamate) after constant 
infusion of low-dose dopamine, 4 months before and 2 months after donor nephrectomy. 
Methods and results. Before donor nephrectomy, GFR was 114±20 ml/min, with a 
reduction to 72±12 ml/min after donor nephrectomy. The dopamine-induced rise in 
GFR of 11±10% was reduced to 5±7% after donor nephrectomy (p<0 .001). Before 
donor nephrectomy, older age and higher B M I  did not affect reserve capacity. After 
donor nephrectomy, the response of GFR to dopamine independently and negatively 
correlated with older age and higher B M I. Moreover, post-donation reserve capacity 
was absent in obese donors. Presence of overweight  had more impact on loss of RC 
in younger donors . 
Conclusions. Donor nephrectomy unmasked an age- and overweight-induced loss of 
reserve capacity. Possibly, donors with advanced age and/or overweight address their 
renal reserve to maintain renal function . 
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Introduction 
The kidney has a substantial functional reserve capacity that is assumed to be relevant 
for preservation of renal function after loss of functional renal mass,  for instance after 
l iv ing k idney donation .  Renal reserve capacity can be estimated from the renal 
hemodynamic response to i ntravenous admin istrat ion of low-dose dopamine, an 
amino-acid solution or an oral protein load (1 -3) . The resu lting increase in glomeru lar  
filtration rate (G FR) is considered to be a reflection of renal  reserve capacity. 
Older age, by loss of nephrons and/or renal arteriosclerosis ,  has been associated with 
reduced renal reserve capacity (4-6) .  In presence of hypertension ,  obese patients were 
also reported to have reduced renal reserve capacity, compared to lean hypertensive 
subjects (7) ,  possibly due to hyperfiltration .  However, data are not consistent, which 
may be due to relatively small study populat ions and differences in patient selection 
(8 ,9) .  In a large series of 1 25 prospective liv ing k idney donors (mean age 49± 1 1  years; 
mean BMI 25±4 kg/m2) ,  we did not find renal reserve capacity to be reduced in older 
or more overweight donors during pre-donation screening ,  presumably because 
kidney donors represent a healthy subset of the popu lation .  However, h igher age and 
higher BMI were i ndependently associated with a larger decrease in renal funct ion early 
after donation ,  suggesti ng i mpai rment in renal adaptive capacity. This had not been 
detected from the renal hemodynamic responses to dopamine and amino acids prior 
to donat ion (1 0) . 
Effects of age and overweight on renal r isk after living kidney donation is of clinical 
relevance, as - due to persistent donor shortage - o lder and/or overweight subjects are 
increasingly accepted for k idney donat ion .  Th is implies that the long-term renal risk  
profile fo r  the current donor  population may not  be sim ilar to  that o f  the former, 
healthier, donor population (1 1 ). 
After kidney donation ,  renal hemodynamic reserve capacity is decreased (1 2-1 4) , most 
likely resu lt ing from a state of renal vasodilatation that occurs in the remaining kidney 
as part of the compensatory response (1 2) .  It is unknown whether renal reserve 
capacity after kidney donation is affected by risk  factors for renal funct ion loss ,  such as 
o lder age and higher body mass index .  
Based on the above studies , we hypothes ized that the decrease in renal reserve 
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capacity after kidney donation would be larger in o lder and in overweight subjects . To 
test this hypothesis , we analyzed data on renal reserve before and early after donat ion 
in 1 78 l i ving kidney donors and analyzed for the impact of age and BM I .  
Methods 
Subjects 
The study popu lation cons isted of 1 78 consecutive l iving k idney donors (age 48± 1 1  
years , 3 9 %  male, mean B M I  25 .5±4. 1  kg/m2) w h o  u nderwent t h e  screen ing protocol 
with subsequent donation in the Un ivers i ty Med ical Center Gron ingen between 1 984 
and 2005. All donors were normotens ive or with wel l - regu lated blood pressure by 
maximum of one antihypertens ive drug (8 subjects) , they did not have a h istory of 
d iabetes ,  k idney disease or card iovascu lar events .  Potent ia l  donors with latent 
d iabetes ,  identif ied by abnormal oral g lucose to le rance test , were excluded from 
donation .  Phys ical examinat ion did not reveal abnormal findings .  In our center, 
g lomeru lar f i l tration rate (G FR) and its reserve capacity are routinely measured as part 
of the l iv ing donat ion protocol .  As described below, GFR was measured as the 
clearance of 125 I - iothalamate, f irst without stim ulat ion ,  and d i rectly hereafter du ring 
stimu lat ion by low-dose dopamine .  Measurements were perfo rmed 4 months before 
and 2 months after kidney donat ion . All donors consented with the use of the i r  cli n ical 
data for study purposes. 
Renal hemodynamic measurements 
GFR was measured by comb ined constant infusion of radio- labeled tracers 
125 I -iothalamate and 131 I -h ippurate , the donors be ing in a q u iet room,  in the semi-sup ine 
pos i t ion .  After d rawing a b lank blood sam ple , a pr im ing solution contai n ing 0 .04 m l/kg 
body weight of the infus ion solut ion (0 .04 M Bq of 125 I - iothalamate and 0 .03 MBq of 
131 1 -h ippurate) plus an extra of 0 .06 M Bq of 125 I - iothalamate was given at 08 .00 hours 
a .m . ,  fo l l owed by infusion at 1 2  m l/h .  In order to atta in stable plasma concentrations of 
both tracers ,  a 2-hour stab i l izat ion period fo l lowed , after which baseline measurements 
started at 1 0 .00 hours a .m .  The clearances were calcu lated as (U*V)/P and ( l *V)/P, 
respectively. U *V represents the ur inary excretion of the tracer, l*V represents the 
infusion rate of the tracer and P represents the tracer value i n  plasma at the end of each 
clearanc e  period .  This m ethod corrects for incom plete bladder emptying and dead 
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space, by multiplying the urinary clearance of 1 25I-iothalamate with the ratio of the 
plasma and urinary clearance of 131 I-hippurate (15). 
To obtain reserve capacity, the above-described baseline procedure was extended for 
2 hours. During this period, dopamine was infused at a rate of 1 .5  µg/kg per minute. 
GFR during these 2 hours was compared with baseline GFR and expressed as a 
percentage. 
Body mass index (BMI) was calculated as (BODY WEIGHT / LENGTH2) and divided into 
classes as follows: normal weight: BMl<25 kg/m2, overweight: BMI 25-29.9 kg/m2 , 
obesity: BMl2::30 kg/m2 • 
Statistical analysis 
Data are presented as mean±standard deviation unless stated otherwise. Associations 
were analyzed by univariate analysis (Pearson). In addition, multi-linear regression 
analysis was applied with age and BMI as independent variables entered into the 
regression equation and renal hemodynamic parameters (proportional rise in GFR) as 
dependent variables. Influence of donor age on renal function and reserve was 
assessed by age as a continuous variable as well as by tertiles of age. Differences in 
reserve capacity between BMI classes were analyzed by analysis of variance (AN OVA) 
followed by post-hoc analysis (LSD) to account for multiple comparisons. Furthermore, 
we applied ANOVA and post-hoc analyses to reserve capacity in the different tertiles of 
age. To account for possible interaction between BMI and age, the interaction term was 
calculated as BMl*AGE, and analyzed as a continuous variable. Finally, ANOVA and 
general linear modeling were applied to the combination of BMI and age. Statistical 
analyses were performed by using SPSS version 14.0 software (SPSS Inc., Chicago, IL, 
USA). A p-value less than 0.05 was considered statistically significant. 
Results 
Characteristics 
39% of donors were male. Mean donor age was 48±11 years and mean BMI was 
25.5±4.1 kg/m2 . The population characteristics are given in Table 1a for break u p  by 
BMI class and in Table 1 b for break up by tertiles of age. Before kidney donation, 
89 
CHAPTER 5 
Normal (n=87) Overweight (n=70) Obese (n=21 ) p-value (ANOVA) 
Before donation 
Age (years) 46±11  49±1 1 52±8 0.072 
Body mass index (kg/m2) 22.4±1 .7 27.0±1 .4 33.5±3.7 <0.0001 
Percentage male donors 34% 47% 33% NS 
GFR baseline (ml/min) 1 1 1 ±1 5  1 1 7±23 1 1 9±24 0.070 
GFR on dopamine (ml/min) 1 22±1 9 1 29±28 132±27 0.1 03 
Serum creatinine (mg/dl) 1 0.9±0.1 1 .0±0.1 0.9±0.1 0.1 1 7  
After donation 
GFR baseline (ml/min) 70±1 1 74±13  74±1 1  0.1 03 
GFR on dopamine (ml/min) 75±14 77±13  76±12  0 .776 
Serum creatinine (mg/dl) 2 1 .3±0.2 1 .4±0.2 1 .3±0.2 0.009 
Data are provided as mean±standard deviation; normal weight: BM l <25,  overweight :  BMI  25-29.9, obese: 
BM l�30. AN OVA was used to test the differences between the weight classes. Creatin ine in  µmol/L: 1 before 
donation ,  normal weight 83±1 1 ;  overweight 86±1 3 ;  obese 80±1 1 ;  2 after donat ion ,  normal weight 1 1 1 ±17 ;  
overweig ht 1 20±19 ;  obese donors 1 1 5±20. Abbreviations: BM I ,  body mass index ; GFR, glomerular filtration 
rate; ANOVA, analysis of variance. Dopamine-stimulated GFR values compared to baseline values: both 
p<0.001 , before as well as after donation (paired I-tests for total group). 
1 •1 tertile (n=87) 2•1 tertile (n=70) 3•1 tertile (n=21) p-value (ANOVA) 
Before donation 
Age (years, range) 21 -45 46-53 54-75 <0.001 
Body mass index (kg/m2) 24.3±4.3 25.8±3.9 26.5±4.0 0.01 2 
Percentage male donors 40% 37% 40% NS 
GFR baseline (ml/min) 1 23±1 9 1 1 3±1 9 1 05±17  <0.001 
GFR on dopamine (ml/min) 1 35±23 1 27±23 1 1 6±22 <0.001 
Serum creatinine (mg/dl) 1 0.9±0.1 0 .9±0.1 1 .0±0.2 0.863 
After donation 
GFR (ml/min) 77±10 72±12  66±10  <0.001 
GFR on dopamine (ml/min) 83±11  77±13 68± 1 1  <0.001 
Serum creatinine (mg/dl) 2 1 .3±0.2 1 .3±0.2 1 .3±0.3 0.094 
Data are provided as mean+standard deviation unless stated otherwise. ANOVA was used to test the 
differences between the tert i les .  Creatin ine in µmol/L: 1 before donation , first terti le 84±9; second tertile 
83±1 1 ;  third terti le 84±1 5 ;  2 after donation, first terti le 1 1 2±16 ;  second terti le 1 1 4±16 ;  third terti l e  1 1 9±23.  
Abbreviations: G FR, g lomerular f i ltration rate; ANOVA, analysis of variance. 
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Renal reserve capacity is expressed as the percentage rise in GFR after infusion of low-dose dopamine. 
There were no statistically s ignificant differences in  pre-donation reserve capacity between the groups of 
BMI  or age (all ANOVA p>0.10). After donation, reserve capacity was more reduced in donors with h igher 
BMI and older age, l isted in detail below. 
A Post-donation reserve capacity differs between BMI  class: p=0.005 (ANOVA). Post-hoc analyses :  
overweight vs .  normal weight p=0.086, overweight vs. obese p=0.046. Obese vs .  normal weight 
p=0.002. Normal weight: n=87; overweight: n=70; obese: n=21 . 
B Post-donation reserve capacity differs between tertiles of age at donation: p=0.006 (AN OVA). 
Post-hoc analyses: oldest vs. middle terti le p=0.036. Oldest vs. youngest tertile p=0.002. 
Abbreviations; BM I ,  body mass index; G FR ,  g lomerular filtration rate. 
baseline GFR was 1 1 4±20 ml/min , with a reduct ion to 64±7% of pre-donat ion values 
after donation (p<0 .001 ) .  Before donation ,  i nfusion of low-dose dopamine sign i ficantly 
increased GFR to 1 26±24 ml/min ,  p<0.001 versus baseli ne .  After donation ,  infusion of 
low-dose dopamine induced an increase in GFR from 72±12  ml/min to 76±1 3  ml/min 
(p<0.001 versus post-donation baseli ne values) . 
Pre-donation GFR was h ighest in obese donors , however, this was merely of borderline 
statistical significance (ANOVA p=0.07) .  As ant ic ipated ,  G FR was significantly lower in 
the older age g roups,  before as well as after donation (Table 1 ) .  
Influence of BM I  or  age on  renal reserve 
Figure 1 shows the percentage change in G FR after stimulation with dopamine before 
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Data are expressed as mean:tstandard error. Four groups of equal size were obtained by dividing first 
across median age and second across median BMI of either group. Group 1 (reference group) : age549 
and BMl<24.2  (n�44); group 2 :  age549 and BM l2!:24 . 2  (n 45); group 3: age>49 and BM l<25 .8  (n=44); 
group 4: age>48.9 and BM l2!:25.8 (n= 45). P<0.001 by ANOVA. Compared to reference group 1, there was 
a statistically s ignificant lower reserve capacity in G FR in donors from group 2 (p=0.04), 3 (p<0.001)  and 
group 4 (p<0.001 ; a l l  post-hoc analyses) . Whereas RC was reduced to a greater extent in  younger donors 
with overweight ,  in  older donors, being normal weight or overweight did not inf luence the amount of renal 
reserve reduction (p=0.65 post-hoc) . 
age (lower panel ) .  The mean rise i n  GFR for the whole population was 1 1 ±1 0% before 
and 5± 7% after donation (p<0.001 before vs. after). As shown in F igure 1 ,  before 
donat ion ,  reserve capacity was s imi lar for the d ifferent BM I  classes and the tertiles of 
age .  respect ively. After donation ,  however, reserve capacity was progressive ly lower 
with increas ing BMI and increas ing age (a l l  ANOVA p�0.01 respectively, see F igure 1 ) .  
I n  obese donors, t he  response of GFR to  dopamine d i d  not reach statist ical s ign if icance 
anymore, so post-donation reserve was no longer demonstrable (one-sample t-test 
p>0 . 1 0) .  This was not the case for donors in the h ighest terti le of age. When analyzed 
as a continuous variable ,  before donation ,  renal responses were not related to age or 
B M I .  After donation ,  again , older age (r=-0. 28, p<0.001 )  and higher BM I  (r=-0 .26 ,  
p< 0 .001 )  were negatively associated wi th the response of  GFR to dopamine .  
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Combined effect of BMI  and age on post-donation renal reserve 
Older age and higher B M I  are usually associated, so it is relevant to investigate both 
their independent and their combined effects. In our population , age positively 
correlated to B M I  (r=0.19, p=0.01). When partial univariate correlation analyses were 
applied to correct for either B M I  or age, the negative association remained intact 
between reserve capacity on the one hand and B M I  or age on the other hand (p=0 .001 
and p=0 .008 , respectively). On multivariate analysis , both age (p=0 .001) and B M I  
(p=0.003) were independent negative predictors of the GFR response to dopamine. 
The predictive power of this model was limited however, with R2 of 0.13. 
To illustrate the potential combined effects of age and B M I  on reserve capacity, we 
plotted post-donation reserve capacity for four groups created by dividing first across 
median age (49 years) and second across median B M I  of both groups obtained (24 .2 
kg/m2 for younger donors and 25.8 kg/m2 for older donors) as shown in Figure 2. Post­
donation reserve capacity was lowest in donors who were both older and overweight. 
There was a statistically significant difference between donors with B M I  below or above 
the median in the younger age group (p=0 .04). In the older age group, however, there 
was no difference in RC between donors with or without overweight (p=0.65). 
To quantify the combined effects of B M I  and age on renal reserve capacity, B M l*AGE 
was analyzed as interaction term. On multivariate regression analysis , there was a 
statistically significant contribution for B M I  and age as independent predictors for post­
donation renal reserve, with a borderline significance for the interaction term B Ml*AGE 
(see Table 2 for model). General linear modeling showed a significant interaction 
between B M I  and age (R2=0.17, p<0.001), with B M I  in classes and age in tertiles. 











R2 0.14 ;  p<0.0001 
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The donation-induced decrease in reserve capacity is plotted for age below or above the median and 
different classes of BM I .  Younger donors (age below median of 49 years) with normal weight (BMI below 
25) had a statistical s ignificant smaller decrease in reserve capacity compared to o lder donors with normal 
weight (p=0.005; post-hoc analysis). However, when overweight (BM I  25-30) or obesity (BM l2:30) was 
present, there was no longer a difference between younger or older donors. Furthermore, for younger 
donors, loss of renal reserve was profound when obesity was present (p-=-0.023 obese vs. normal weight 
donors with age below the median; post-hoc analysis). For older donors, body mass index did not inf luence 
the degree of loss of renal reserve. 
Figure 3A shows the effect of overweight or obesity on renal reserve capacity by age 
group (cut-off at median age, ANOVA p=0.002). There was a statistically significant 
difference in RC between younger and older donors with normal weight (post-hoc 
p=0.005). However, when overweight or obesity was present, there was no longer a 
difference between younger and older donors (p=0.1 16 and p=0.594, respectively). 
Determinants of the post-donation decrease in reserve capacity 
On univariate analysis, both BMI (r= -0.22, p=0.003) and age (r=-0.20, p=0.006) were 
negatively correlated to the change in renal reserve capacity. Univariately, the 
interaction term BMl*AGE correlated to the decrease in RC (r=0.26, p=0.001). 
Multivariate regression analysis showed both factors to be independent determinants 
of the decrease in reserve capacity. On general linear modeling -entering BMI in 
classes and age in tertiles- the interaction term was a significant independent variable 
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in predicting post-donation renal reserve capacity (R2=0.14), with a p-value of 0.002. 
This is visualized in Figure 3B, which shows in a simplified model that BMI has 
considerable impact on the decline in reserve capacity in younger, but not older, 
donors. 
Discussion 
This study, the largest so far on renal reserve capacity before and after living kidney 
donation, confirms our hypothesis that the decrease in renal reserve after kidney 
donation is higher in older and overweight donors. Higher age and BMI were 
independently associated with a lower reserve capacity, whereas this was not the case 
in the same subjects prior to donation. 
Renal reserve capacity after kidney donation has been studied in several prior, smaller 
studies (12-14,16,17). All studies document presence of reserve capacity after donation. 
Comparable to our results, renal reserve capacity tested with dopamine was found to 
be almost halved in kidney donors (12,13,16). This has been interpreted as a reflection 
of compensatory hyperperfusion and hyperfiltration of the remaining kidney. In our 
study, renal reserve after donation was reduced more in donors with advanced age and 
higher BMI. Moreover, we found post-donation reserve capacity of GFR to be 
completely annihilated in obese donors. So these factors, that were already documented 
to be associated with post-donation renal function impairment (10,18), are also 
associated with a marked reduction in renal hemodynamic reserve capacity, which may 
be due to a state of vasodilation as part of the compensatory response after unilateral 
nephrectomy. Long term renal monitoring would be important to investigate whether 
this response pattern after donor nephrectomy is associated with an increased risk for 
renal function loss. 
Prior studies have reported a decrease in reserve capacity in older subjects, albeit not 
invariably so (4,8,9). In our large population, we did not detect an effect of age on 
reserve capacity prior to kidney donation. This may be due to the fact that kidney 
donors represent an above-average healthy subset of the population, in whom GFR 
was also relatively well-preserved, albeit lower than in younger subjects. Remarkably, 
donor nephrectomy elicited an age-related effect on renal reserve capacity. Effects of 
age on renal reserve have been attributed to impaired vasodilator response due to 
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arteriosclerosis in the kidney's interlobular and arcuate arteries (6). Apparently, in our 
older subjects, the condition of the renal vasculature allowed for an appropriate 
response do dopamine before donation. After donation, due to compensatory vasodi­
lation elicited by the nephrectomy, further vasodilation capacity was limited, possibly 
explaining the underlying effect of age on renal reserve. 
As to the effect of BMI, one prior study documented a reduced reserve capacity in 
obese hypertensives compared to lean hypertensives (7). Our study is the first to 
document an adverse effect of BMI on reserve capacity in normotensive subjects. 
Again, this effect was not present before donation, but was elicited by donor 
nephrectomy. 
Previously, we found both higher BMI and age to be risk factors for renal function 
impairment, defined as a GFR below 60 ml/min/1.73 m2 (or CDK stage Ill) (10). Now, 
we report on both factors to be associated with reduced post-donation renal reserve 
capacity. Impact of loss of renal reserve on long-term renal function in living kidney 
donors is currently unknown, but analyses are ongoing. Since higher BMI has in 
particular been associated with h igher risk for renal damage after nephrectomy (1 8), 
our findings of a reduced post-donation renal reserve in kidney donors with higher BMI 
may be of clinical relevance. Finally, we observed that presence of overweight had 
more impact on loss of reserve capacity in younger donors. Younger donors with 
overweight or obesity displayed a loss of renal reserve that was similar to the loss of 
reserve of older donors which was irrespective of BMI. Moreover, in obese donors, the 
capacity to increase GFR to low-dose dopamine was annihilated after donation. Our 
current study design, with only a brief duration of follow-up after donation, does not 
allow to substantiate the clinical significance of this finding. Theoretically, absence of 
reserve capacity might be an unfavorable prognostic sign, indicating glomerular hyper­
filtration, which could be harmful in the long run. Long-term follow-up studies are 
needed to document a possible effect of post-donation loss of reserve capacity in 
predicting long-term renal prognosis. In th is respect, it is relevant to note that weight 
loss has been shown to correct obesity induced hyperfiltration (19), so a potentially 
favorable intervention is available. 
We emphasize the need for donor follow-up especially when obesity is involved in 
younger donors, since these donors are potentially exposed to an increased renal risk 
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for a long period of time. Though a potential benefit from weight loss, low protein diet 
and/or ACE inhibition remains to be investigated, weight loss should be stimulated in 
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CHAPTER 6 
Introduction 
The studies described in this thesis were motivated by the increasing recognition that 
obesity is a risk factor for renal damage in native kidney disease (1 -3) and in renal 
transplant recipients (4-9). Several factors that are usually associated with obesity, such 
as hypertension, insulin resistance and diabetes, are likely to be involved in the 
increased renal risk in obesity. However, also in the absence of these factors, obesity 
is associated with an unfavourable renal hemodynamic profile that may play a role in 
the susceptibility and progression of chronic renal damage. More specifically therefore, 
this thesis focuses on the renal hemodynamic profile in overweight and obesity in man, 
and its possible impact on renal risk. 
As discussed in Chapter 1 the prevalence of overweight and obesity has dramatically 
increased in the last two decades. Obesity seems to become the major health problem 
of the 21st century as it is associated with increased morbidity and mortality, mainly due 
to an elevated cardiovascular risk, with insulin resistance and diabetes, dyslipidemia 
and hypertension as most important risk factors. However, obesity is also a risk factor 
for renal damage - in native kidney disease (1-3), in renal transplants (4-9) and after 
uninephrectomy (10). Considering the pandemic of obesity and overweight, therefore, 
weight excess may turn out to become the main risk factor for renal damage in the 
decades to come. 
In this final chapter the studies described in this thesis will be put into the wider 
perspective of the currently available data on the impact of obesity and overweight on 
renal hemodynamics, with the main emphasis on human data. We will discuss its 
possible underlying mechanisms and the implications for long-term renal risk. Finally, 
we discuss interventions that have potential to limit the renal risks of obesity. 
Measurement of renal hemodynamics 
Measurement of renal hemodynamics by clearance techniques 
Current evidence on the role of renal hemodynamics as a factor in progressive renal 
function loss has mainly been derived from rat studies, where micropuncture allows 
direct assessment of glomerular flow and pressure. In remnant kidney models it has 
convincingly been shown that changes in renal hemodynamics leading to glomerular 
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hypertension are important pathogenetic factors in progressive renal damage (11-15). 
In animal models of obesity it has been shown that alterations in the glomerular 
microcirculation resemble those after renal ablation, with glomerular hypertension and 
hyperfiltration at the single nephron level (16 ;17), as will be discussed in more detail in 
the next paragraph. 
In humans on the other hand glomerular flow and filtration pressure cannot directly be 
measured. Current knowledge on renal hemodynamics in man is therefore derived from 
indirect assessment of renal hemodynamics by cleararance techniques. Accurate 
assessment of glomerular filtration rate (GF R) and effective renal plasma flow (ERPF )  
can be obtained by measuring the renal clearance of specific markers, such as 
125 1 -iothalamate, 99mTc-diethylenethiaminepenta-acetic acid, 51Cr- ethylenediaminetetra­
acetic acid, or inulin for GFR, and 131 1 -hippurate or para-amino-hippuric acid for ERPF, 
respectively. When GFR and ERPF are measured simultaneously, filtration fraction ( FF )  
can be  calculated as the ratio from GF R and ERPF. F F  can be  a helpful parameter to 
interpret changes in GFR in terms of the underlying hemodynamic changes. When a 
rise in GF R is primarily related to hyperperfusion, it will be associated with a proportio­
nal rise in ERPF and thus unaltered F F. When a rise in GFR is primarily due to a change 
in filtration pressure, this will be apparent as a rise in F F, as ERPF will be elevated less 
than GF R. A rise in filtration pressure is assumed to be unfavourable in terms of long 
term renal risk, as longstanding glomerular hypertension was proven to be involved in 
progressive renal damage in numerous animal studies. These data are supported by 
indirect evidence in human studies as well, demonstrating the prognostic impact of 
changes in F F  during therapy for long term renal outcome (18;1 9). For these reasons, 
FF is considered a surrogate parameter for glomerular hypertension in man. 
It should be mentioned, however, that GF R measurements in man can be misleading in 
the assessment of glomerular hyperfiltration, as clearance measurements reflect the 
total filtration rate of all nephrons together, so a GFR within the normal range may reflect 
a normal pressure/GFR in a normal nephron number, but also an elevated pressure/ 
GFR in a decreased number of nephrons without a possibility to distinguish between 
these conditions. Only if GF R is elevated, one can be sure that single nephron GF R is 
elevated as well. 
Estimation of renal function by using creatinine-based equations 
Measurement of GFR by specific tracers is expensive and time consuming. Therefore, 
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for clinical and epidemiological purposes GFR is usually estimated from serum 
creatinine by renal function equations that i nclude antropometric  indices such as age, 
weight and gender to account for between-individual differences in muscle mass and 
the consequent differences in creatinine generation. Many equations are avai lable, 
mostly empirically developed in populations with native kidney disease (20-37). 
However, these equations are subject to bias that can substantial ly confound evaluation 
of the association between obesity and renal function, as in obesity a higher body 
weight is usually associated with a higher fat mass, but not a h igher muscle mass, 
whereas the weight-factor in the equation is assumed to reflect muscle mass. In  
Chapter 2 we evaluated this bias in transplant recipients, showing that. at  higher BMI, 
the MORD equation progressively underestimated, and the Cockcroft-Gault equation 
progressively overestimated GFR. Presence of BMl-dependent bias is in line with data 
in native kidney disease. In a relatively small population, the Cockcroft-Gault equation 
underestimated GFR at low BMI, and overestimated GFR at high BMI, whereas for the 
MORD equation the BMl-dependent bias was of borderline significance, and the 
recently developed equation by Rule showed progressive overestimation of GFR at 
high BMI (34). Thus, bias in the equations by Cockcroft-Gault and Rule can erroneously 
suggest presence of hyperfiltration at high BMI (38)! These shortcomings hamper the 
interpretation of epidemiological analyses of the association between obesity and renal 
function. Currently, the MORD equation has become the standard for estimation of 
GFR, as its overall predictive performance in different populations is better than for 
other equations, but it is recognized that better equations are warranted. 
Another issue relevant to renal function estimates in obesity is the normalization of data 
to body surface area (BSA). This applies to renal function equations as well as accurate 
renal function measurements. Renal function indices are usually expressed per 1.73m2 
BSA, as standard reference body size. However, excess weight does not only lead to a 
rise in BM I ,  but also to a rise in BSA. Thus, when an individual gains weight, BSA­
normalized kidney function would "decrease", in the absence of a true change in renal 
function. Likewise, BSA-normalization may confound comparisons between obese 
subjects and non-obese control populations, as illustrated by Schmieder et al who 
found a lower BSA-corrected ERPF in obese subjects compared to lean subjects (39), 
whereas height-corrected and uncorrected ERPF were not different. Similar findings, 
also for GFR, were shown by Anastasio et al (40). For these reasons it has been 
proposed that normalization for height would be more appropriate, albeit no consensus 
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Ref. N Population BMI GFR ERPF Normalization Renal hemodynamics 
for in obese subjects 
vs non-obese controls 
(1 05) 42 HT 31 hippurate height i RBF in normotensive 
and hypertensive obese 
(41) 60 HC/HT 32 Tc-DTPA hippurate height i GFR and i ERPF in 
Obese, obesity, 
non-obese i FF in HT obese only 
(46) 64 HC/HT 34 Tc-DTPA hippurate - ERPFJ, and i FF in 
centrally obese HT 
(48) 45 Healthy 29 - xenon kidney i RBF in obese, on low 
moderately volume sodium diet only 
obese 
(40) 20 Severely 47 inulin hippurate BSA No differences 
overweight, 
normotensive 
(2) 1 2  Severely 44 inulin hippurate i GFR; i ERPF; i FF 
obese with IR 
(45) 8 Severe 48 inulin hippurate - i GFR; i RPF; i FF 
obesity/ IA ,  correction by 
Weight reduction weight loss 
(1 06) 1 02 Healthy 24 iothalamate hippurate BSA and i FF with higher BMI 
height 
N number of overweight/obese patients GFR glomerular filtration rate 
HC healthy controls ERPF effective renal plasma flow 
HT hypertensive subjects RBF renal blood flow 
IR insulin resistance BSA body surface area 
BMI body mass index 
exists as yet (41). For analysis of the studies described here we used uncorrected 
values of GFR and ERPF, as well as values corrected for height. At any rate, filtration 
fraction (FF), the ratio of GFR and (E)RPF, is not affected by the adopted method of 
normalization, and can be interpreted to reflect true differences between obese and 
non-obese subjects. 
Impact of obesity on renal hemodynamics 
Several experimental studies addressed the impact of obesity on renal hemodynamics. 
Multiple studies were done in obese Zucker rats, a genetic model of obesity associated 




Micropuncture studies (16;17;42;43) revealed an elevated GFR, which was attributable 
to an increased single nephron plasma flow rate as well as glomerular transcapillary 
hydraulic pressure. The elevated GFR, however, was n ot a prerequisite for the 
development of structural damage in this model (42;43). Also, in diet-induced animal 
models of obesity, an elevated GFR is usually documented (44). 
Human studies on the impact of obesity and overweight on renal hemodynamics, 
including our own analysis from Chapter 3 in healthy subjects, are summarized in the 
Table. To avoid the BMl-dependent bias inherent to renal function equations, only 
studies using accurate clearance methods are included here. It shows that an elevated 
GFR was found in most, but not all studies. Frequently, but not always, this was 
accompanied by an elevated ERPF and/or an elevated FF. From measuring dextran 
sieving curves, and entering these data in a theoretical model on the determinants of 
filtration, Chagnac et al could attribute the elevated GFR in severe obesity to an 
increase in transcapillary hydraulic pressure, � P (2). A more recent study of this group 
is of special interest as well, as it provides renal hemodynamic data before and after 
weight loss by bariatric surgery (45). A massive weight loss of 48 kg in n ine morbidly 
obese, non-diabetic subjects over a period of 12-17 months, with a decrease in mean 
BMI from 48 to 32 kg/m2 , resulted in a decrease in GFR of 145±14 to 110±7 ml/min 
(versus 92±4 ml/min in controls), with corresponding decreases in RPF, FF, albuminuria, 
and blood pressure, along with improvement in insulin resistance. 
For the five studies that analyzed both GFR and renal perfusion (41 ;46;2;40;45) in 
obese subjects and controls an overview of the mean values for GFR, ERPF and FF is 
given in Figure 1, ranked by BMI (from left to right). For the two studies that provide data 
for hypertensives separately (41 ;46) data are given by a break-up by presence or 
absence of hypertension. The overview shows that in the studies reporting a difference 
between obese and non-obese subjects, the difference is usually in the same direction, 
namely hyperfiltration (elevated GFR), hyperperfusion (elevated ERPF) or elevated 
glomerular pressure (FF). In two of the studies an effect of obesity was present only 
under specific conditions. In the study by Ribstein et al obesity was associated with 
altered renal hemodynamics in hypertensive, but not in n ormotensive subjects (41), and 
in the study by Scaglione FF was elevated (and renal plasma flow reduced) in 
hypertensives with central obesity (presumably reflecting insulin resistance) only, but 
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Five studies (41 ;46;2;40;45) showing the impact of overweight and obesity on glomerular filtration rate (GFR), 
effective renal plasma flow (ERPF) and filtration fraction (FF) respectively. Bars left of dashed line show 
non-hypertensive subjects, bars right of dashed line show the hypertensive subpopulation of study 1 and 2. 
peripheral obesity (46). These data illustrate the relevance of the interaction between 
obesity/overweight and its frequent co-morbid conditions such as hypertension and 
insulin resistance for renal hemodynamics. The presence of hypertension may result in 
differences in ERPF in particular as in established hypertension usually a decreased 
ERPF is found, with a preserved GFR, and consequently and elevated FF (47). Thus, as 
to FF the effects of hypertension and obesity are in the same direction, but as to ERPF 
their effects are opposite. Moreover, sodium intake may be relevant as well; Porter et al 
found an elevated renal plasma flow in moderately obese, healthy hypertensives as 
compared to normotensive controls during a severe dietary sodium restriction, but not 
during a liberal sodium diet (48). The mechanism underlying this effect of sodium status 
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Scatterplot showing the univariate correlation 
between body mass index (BMI )  and filtration 
fraction (FF) in healthy subjects. Adapted from 
Bosma et al (1 06). 
Overweight and obesity can modulate renal hemodynamics also in the absence of 
co-morbid conditions, as apparent from the other stu dies in Figure 1 .  Our own data 
(Chapter 3) provides strong evidence for an independent role of weight excess .  We 
found a relationship between a higher B M I  and a higher FF in a population of normal 
subjects, well-documented to be healthy and with a B M I  not exceeding 30 kg/m2 
( Figure 2). This demonstrates , first, that excess weight is associated with altered renal 
hemodynamics even in the absence of overt obesity without an apparent lower 
threshold, and second, that the impact of weight excess on glomerular hemodynamics 
does not depend on presence of co-morbid conditions .  Nevertheless ,  as apparent 
from the above studies, when hypertension and/or insulin resistance are concomitantly 
present, their renal manifestations may interact with those of the excess weight, and 
thu s  account for some of the discrepancies between studies . 
It should be noted that many other factors can modulate the effects of overweight and 
obesity on renal hemodynamics as well. These include age (49), sodium intake, drug 
use, and possibly also the severity of obesity, although the overview in Figure 1 does 
not support the latter. The respective effects of age and B M I  on GFR are illustrated in 
Figure 3, showing cross-sectional data in healthy subjects. BM l-associated hyperfiltra­
tion was only present in young adults bu t in older subjects GFR was similar for those 
with a B M I  above or below the median . This suggests a steeper age-related decline in 
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subjects with higher BMI, but also that BM I-associated hyperfiltration in young adults is 
relatively innocent in terms of renal risk at an older age. However, these are cross­
sectional data, in selected healthy subjects with a BMI not exceeding 30 kg/m2. 
A proper interpretation in terms of presence of absence of long-term renal risk induced 
by hyperfiltration would therefore require longitudinal data, also in subjects with the 
usual co-morbid conditions. 
It should be noted moreover, that the renal hemodynamic status in adults and older 
subjects also depends to a considerable extent on their prior medical history as 
regards longstanding hypertension and cardiovascular disease and the resulting 
presence of subtle renal end organ damage (49;50). Obviously, this is all the more true 
for population with an underlying primary renal condition. Whether BMI modulates renal 
hemodynamics in patients with a primary renal disorder would be of great interest, but 
has not been investigated so far. For renal transplant recipients we investigated the 
impact of obesity on renal hemodynamics as described in Chapter 4. It is well­
recognized that a higher BMI of the recipient is associated with renal risk after renal 
transplantation (4-9). Whether this increased renal risk is due to altered renal 
hemodynamics, i.e. a hyperfiltration pattern in the transplanted kidney, was so far 
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Adapted from Bosma et al (1 06). 
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unknown. It was not known whether BMI is relevant to renal hemodynamics in renal 
transplants in the first place. It should be emphasized that extrapolation of data from 
native kidneys to transplanted kidneys would not be justified, as in the renal transplant 
many other factors are present that could affect renal hemodynamics and thus overrule 
an effect of BMI, if any. These include use of calcineurin inhibitors, the single kidney 
state and presence of intrinsic renal damage. Of note, as opposed to native kidneys, 
the transplanted kidney is denervated. Furthermore, the transplanted kidney provides 
an interesting model system, as the genetic backgrounds of the kidney and the 
recipient are different. Thus, for various reasons it would be relevant to establish 
whether a higher recipient BMI is associated with a specific hemodynamic profile in the 
transplanted kidney. Moreover, it would be interesting to know whether the association 
between higher BMI and worse renal outcome can be attributed to altered renal 
hemodynamics. These questions were addressed in Chapter 4, in which we describe 
a cross-sectional association between BMI and renal hemodynamics in a large 
population of renal transplant recipients, with evaluation at 1 and 5 years after 
transplantation respectively. In line with the data in the healthy subjects described in 
Chapter 3, we showed an impact of BMI on GFR and FF in the transplant population 
as well, with a higher GFR and FF at one year after transplantation in recipients with a 
higher BMI. The impact of BMI on renal hemodynamics was not explained by the 
presence of overt diabetes mellitus. Survival analysis revealed that a lower GFR and a 
higher FF were independent determinants of overall graft loss and graft loss by patient 
mortality. Lower GFR and higher BMI were determinants of death-censored graft loss, 
with a contribution of a higher FF as well. To our knowledge, this is the first study 
demonstrating the predictive effect of a higher FF for a worse long term renal outcome 
in man. So far, in human the evidence for an independent pathogenetic role of renal 
hemodynamics was of an indirect nature (18;19). As shown in Figure 4 for a given (low) 
GFR, in subjects with a higher FF long term outcome is worse than in subjects with a 
low FF, i.e. subjects in whom filtration rate is obtained at a lower filtration pressure. It 
would be highly interesting to have similar data for native kidney disease, but so far, 
such data are not available. 
Measurement of renal reserve capacity 
As noted above, for the purpose of detecting hyperfiltration the interpretation of whole 
kidney clearance measurements can be cumbersome and hyperfiltration at the single 
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from Bosma et al (1 07). 
strategies have been developed to address the issue of hyperfiltration. These strategies 
start from the assumption that a decrease in filtration reserve is a sign of hyperfiltration. 
The normal kidney has a considerable filtration reserve, as for instance apparent from 
the immediate rise in GFR and ERPF in the remaining kidney after donation, from the 
considerable rise in GFR and ERPF in pregnancy, and from the responses to several 
renal vasodilators. Several protocols have been developed to assess the reserve of 
filtration and perfusion, respectively, from the renal responses to specific renal 
vasodilators, alone or in combination (51-53). In our centre, the renal responses to 
dopamine, amino acids and their combination has been routinely in use for a long time 
for this purpose. Dopamine elicits preferential efferent vasodilation (resulting in a rise in 
ERPF that exceeds the rise in GFR), whereas amino-acids give predominantly afferent 
vasodilation, resulting in a prominent rise in GFR, with a less prominent or unchanged 
ERPF. The combination of the two gives both afferent and efferent vasodilation and 
marked increases in GFR and ERPF that exceed those with the two separate 
compounds. Renal reserve filtration capacity may be relevant for maintenance of renal 
function after loss of functional renal mass by disease, or after kidney donation. In this 
concept, loss of nephrons, by for instance kidney donation, or by the aging process, 
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would be associated with reduct ion of renal reserve capacity by us ing the avai lable 
reserve for maintenance of renal function .  Moreover, hyperfilt ration could be 
hypothesized to be unmasked by a loss of reserve capacity, and accord ing ly absence 
or  decrease of filtration reserve could be a marker of sustained s ing le nephron 
hyperfiltrat ion that may have maladaptive consequences by damag ing  rem nant 
g lomeru l i .  To see whether the renal hemodynamic pattern associated with weight 
excess might reflect hyperfi l t ration ,  we investigated the association between BM I ,  renal 
hemodynamics and renal reserve capacity, as d iscussed in Chapter 5. We tested 
whether a h igher BM I  would be associated with a decrease in renal reserve capacity, 
before and after donat ion, also addressing other factors that may affect renal reserve 
capacity, such as older age and loss of nephrons by un inephrectomy. To th is  purpose 
we measured renal hemodynam ics and renal reserve capacity before and after k idney 
donation ,  with analys is for dete rm inants of reserve capacity and showed that, after 
donation ,  a higher BMI was associated with a renal hyperfiltrat ion prof i le .  Higher  BM I  
was not associated with a decrease in renal reserve capacity before donat ion .  
Thus apparently, kidney donation u nmasks hyperfiltration in subjects with h igher BM I .  
We fu rthermore found that o lder age ,  as another possib le factor that m ight decrease 
reserve capacity, was a predictor for predonation FF, however not for FF after donation .  
Mechanisms underlying the obesity-related changes in renal hemodynamics 
Together, the above data suggest that obes ity and overweight are associated with an 
altered afferent-efferent g lomeru lar vasomotor balance. A decreased afferent arteriolar 
tone is present, that a l lows a larger  transmission of the systemic arterial pressure to the 
g lomeru lar capi l lary bed (54) and an increase i n  fi ltrat ion as we l l  as perfus ion .  When 
combined with a relative increase of efferent arterio lar tone the rise in fi l tration i s  more 
prominent than the rise in perfusion ,  as apparent from an e levated f i l tration fract ion .  
The elevated g lomerular transcapil lary hydraul ic pressure as calcu lated by Chagnac et 
al (2) is in line with th is assumption .  Extrace l lu lar volume expansion ,  due to the obes ity­
associated i ncrease in sodium reabsorption ,  can also be expected to contr ibute to 
renal hyperperfus ion and hyperfi ltrat ion .  Furthermore, g lomerulomegaly, as documented 
in obes ity-related focal g lomeru losclerosis (55) ,  should be considered as a possible 
factor involved i n  the hyperfi ltrat ion and hyperperfus ion of obes ity. However, data on 
g lomerular morphology are avai lab le only from subjects i n  whom proteinur ia and renal 
function impairment warrant a renal  biopsy, and no data are avai lable to substant iate 
this assumption for subjects with less severe renal i nvolvement. 
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Insul in resistance 
Excess weight gain, especially when associated with visceral obesity, leads to glucose 
intolerance, insu lin resistance and a compensatory hyperinsu linemia (56), which has 
been associated with sodium retention as well as increased glomerular filtration rate 
(2;57). Dengel et al demonstrated a close correlation between insu lin resistance and 
renal hemodynamics in obese, mildy hypertensive, older subjects (58), in whom a lower 
glucose disposal rate during hyperinsu linemic euglycemic clamping correlated with a 
higher GFR and FF. This association was blunted by a high  sodium diet, i. e. a condition 
of suppression of the renin-angiotensin system. The mechanism underlying the link 
between insulin resistance and renal hemodynamic alterations in obesity has not been 
elucidated yet. Hyperinsu linemia has been suggested to be involved by its stimulating 
effects on sympathetic nervous system activity and vasoconstrictor effects (59-62). 
However, experimental hyperinsulinemia does not lead to elevated FF, neither in acute 
nor in chronic experiments (57;63;64). Whereas the effects of exogenous  insu lin in an 
experimental set-up may not be completely similar to those of endogenous hyperinsu­
linemia, this renders a direct effect of h ig h  insu lin levels less likely, and indirect effects, 
by associated factors, are presumably involved. Indirect evidence from epidemiological 
data suggests that the effects of insulin resistance, as estimated from presence of a 
central fat distribution, can dissociate from those of overweight. In the general popula­
tion-based PREVEND cohort, obesity was associated with hyperfiltration, whereas a 
central fat distribution was associated with a greater risk for mild renal function 
impairment not only in obese, but also in lean subjects (65). Thus, the renal risks of 
obesity may be related more closely to the concomitant presence of insulin resistance 
rather than with the obesity as such . 
Renin-angiotensin system 
Several lines of evidence suggest the renin-angiotensin system (RAS) to be involved in 
the renal hemodynamic changes in obesity. First, circulating components of the RAS 
are elevated in obesity in experimental animals (66) as well as human . In this respect, 
activation of the RAS in adipose tissue has been proposed to provide a link between 
obesity and hypertension (67) by production of angiotensinogen - the substrate for 
renin - by adipose tissue (68). The resulting generation of the effector hormone 
ang iotensin II can elicit hypertension by its vasoconstrictor effects on the peripheral 
vascular bed and by promoting tubular sodium reabsorption . Moreover, in the kidney it 
will elicit efferent vasoconstriction , as manifest from a rise in filtration fraction . Several 
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studies reported correlations between plasma angiotensinogen concentrations, blood 
pressure and BMI (69-71). Moreover, (72) an effective weight loss program reduced 
circulating angiotensinogen, plasma renin activity, aldosterone and ACE activity, as well 
as adipose tissue expression of angiotensinogen. In  humans, Scaglione et al (46) found 
significantly higher plasma renin levels in centrally obese normotensive subjects 
compared to peripheral obese and lean subjects. Ruano et al (73) retrospectively 
studied 100 morbidly obese patients, split up for central and peripheral obesity. In the 
centrally obese patients they found higher levels of plasma renin activity, aldosterone 
and ACE with sodium retention, potassium loss and high insulin levels. After gastric 
bypass these abnormal hormone levels tended to normalize. Hopkins et al showed a 
blunted renal vascular response to angiotensin II infusion in subjects with higher BMI, 
suggesting increased intrarenal RAS activity as well (74). In line with this, a study in 
mice showed that obesity was associated with a tissue-specific increase in ACE activity 
in the kidney (75), but otherwise data on the intrarenal RAS are scarce. 
The renal impact of increased activity of the RAS can also be inferred from the renal 
hemodynamic response to RAS-blockade. The renal vasodilator responses to RAS 
blockade were shown to be directly proportional to BMI in two studies. In 100 healthy, 
normotensive, predominantly overweight and obese subjects (76) a highly significant 
relationship was found between the age- and plasma renin activity-adjusted BMI and 
the renal plasma flow response to captopril, supporting the assumption that a BMl­
associated higher intrarenal RAS activity is involved in renal vascular tone in overweight 
and obesity. A similar relationship was found by Price (77) in 12 type II diabetic patients 
with a wide range of BMI, in whom the rise in RPF elicited by angiotensin-receptor 
blocker irbesartan was directly proportional to BMI, with BMI accounting for 50% of the 
variation in the renal hemodynamic response. These BMl-dependent renal effects of 
RAS-blockade also suggest that RAS-blockade may be a suitable tool to reduce the renal 
risks of obesity - assuming that the renal hemodynamic profile reflects a long-term risk. 
In accord with this assumption, RAS-blockade was shown to reduce proteinuria in 
obese proteinuric patients. Interestingly, in a small study weight loss was as effective 
as RAS-blockade in reducing proteinuria (78). Whether the antiproteinuric effect of 
weight loss relates to renal hemodynamic changes has not been established, but 
theoretically, the reduction in GFR and FF that would be anticipated to occur with 
weight loss can be expected to lead to reduction of proteinuria. 
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Interaction between renal sodium handling and renal hemodynamics in obesity 
Altered tubular sodium handling can affect renal hemodynamics by the tubuloglomerular 
feedback (TGF) mechanism. TGF regulates glomerular hemodynamics by modifying 
afferent arteriolar tone in response to changes in NaCl delivery to the macula densa. 
A lower distal NaCl supply elicits a decrease in afferent tone, thus eliciting a rise in 
glomerular filtration pressure and filtration rate. The ensuing rise in filtered load then 
restores NaCl supply to the macula densa towards its original level (79). Obesity is 
well-established to be associated with increased sodium reabsorption (80-82), 
presumably at the level of Henle's loop. Increased TGF activity can thus contribute to 
the afferent vasodilation observed in obesity. 
The increase in FF  might well be involved in this increased sodium reabsorption, as this 
alters the Starling forces in the peritubular capillaries towards increased sodium 
reabsorption. Recent data, published in abstract form (83) support that the elevated F F  
in obesity is involved in the impaired capacity to excrete excess sodium. 
Interestingly, the impaired sodium excretion in obesity is also related to an impaired 
pressure natriuresis response, in particular in central obesity (76 ;84;85), and has been 
attributed to increased activity of the RAS, of the sympathetic nervous system 
(76;86-88), hyperinsulinemia (89), as well as to compression of the kidneys by excess 
retroperitoneal adipose tissue (90) - and results, with elevated FF, in a vicious circle. 
The impaired sodium excretion of obesity can be considered to act as a two-edged 
sword. First, it contributes to volume expansion and obesity hypertension. The latter is 
well established to be sensitive to sodium intake, and interestingly, the sodium­
sensitivity of blood pressure is attenuated by weight-loss (88). Second, by its effect on 
afferent tone it impairs the glomerular protection against elevated systemic pressure. 
This provides a very plausible candidate mechanism for the renal susceptibility in 
obesity hypertension, although for obvious reasons no human data are available to 
support this assumption. 
The combination of sodium-sensitive blood pressure and an unfavourable renal 
hemodynamic profile is not unique to obesity. It is also observed in sodium-sensitive 
black hypertensives (91), non-modulating hypertension, and sodium-sensitive hyper­
tensives with an unfavourable cardiovascular risk profile and micro-albuminuria (92-95), 
conditions that appear to share an elevated cardiovascular risk as well, and that also 
display a considerable overlap (Figure 5). Of note, in these conditions the unfavorable 
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renal hemodynamic profile is el icited, or aggravated by high  sodium intake (96). Recent 
data from our own group demonstrated that also in overweight, in otherwise heal thy 
young subjects, high sodium intake (12 g/day) elicits a hyperfiltration pattern , with an 
elevated FF and GFR. In these subjects, remarkably, the overweight-associated hyper­
filtration was abolished by a moderate (3 g/day) restriction of dietary sodium (Figure 6). 
So apparently, sodium and weight excess interact as regards renal risk profile, and a 
poor profile is found only when both are simultaneously present. The maladaptation to 
h igh sodium may be worthwhile to consider for its clinical implications .  Whereas in 
obesity the main dietary measures should obviously be aimed at weight reduction , 
moderate dietary sodium restriction may be a useful adjunct to improve the obesity­
associated renal risk profile, all the more so because hypertension in obesity is usually 
sodium sensitive. As the data by Porter (48;58) however suggest that the renal 
hemodynamic abnormalities of obesity can be unmasked, or promoted by a severe 
sodium restriction of around 1 g/day, the renal hemodynamic effects of dietary sodium 
restriction in obesity warrant further study. 
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Interaction between weight excess and sodium intake on renal hemodynamics. Filtration fraction (GFR/ERPF, 
expressed in %) In  95 healthy young men, measured during low (50 mmol Na+/day) and high (200 mmol 
Na+/day) with subjects as their own control, with a break-up by BMI .  Lean: n=77, BM l<25 kg/m2 (mean 
BMI 22.1 ±1.4) ;  overweight: n=18 ,  BM l <25 kg/m2 (mean BMI 26.9±2.4). In  lean subjects high sodium did not 
induce a rise in  FF, but in  overweight subjects high sodium induced a significant rise in FF (p<0.05). 
As a consequence, FF was significantly higher in the overweight subjects during high sodium only. 
Data adapted from Krikken et al (1 08). 
Leptin and the sympathetic nervous system 
Other mechanisms suggested to be involved in the renal effects of obesity are 
increased activity of the sympathetic nervous system, and elevated leptin levels. 
Increased activity of the sympathetic nervous system is well-documented in obesity 
(80;97;98), and studies in experimental animals have shown its involvement in the 
sodium-retention and hypertension of obesity (80). However, its role in the obesity­
associated changes in renal hemodynamics is not well documented. Leptin, an adipo­
cyte-derived hormone that is involved in the regulation of weight by effects on appetite 
and energy expenditure, leads to sympathicoactivation of the kidneys and adrenal 
glands, suggesting that the obesity-associated increase in sympathetic nerve activity 
could be due in part to these sympathetic effects of leptin (97;98). Human obesity is 
often associated with leptin resistance, providing sympathetic underactivity with 
subsequent positive energy balance and weight gain. However, leptin resistance does 
not lead to sympathetic underactivity in the kidneys, as shown by Rahmouni et al (99). 
They examined the role of leptin in hypertension associated with diet-induced obesity 
in mice and demonstrated a preservation of the renal sympathetic but also of arterial 
pressure response to leptin, which could be a candidate mechanism for the elevated 
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cardiovascular risk in obesity. The other way round leptin deficiency, as in the ob/ob 
mou se, leads to decreased arterial pressure, despite severe obesity (100). Whereas 
these results support a role for leptin in obesity hypertension, however, leptin does not 
seem to exert a clear cut effect on renal hemodynamics (11). 
Implications of al tered renal hemodynamics in obesity 
As already noted above, the altered renal hemodynamics in obesity can be considered 
one of the factors underlying sodium retention and sodium-induced hypertension in 
obesity. Moreover, by analogy with diabetic hyperfiltration and with remnant kidney 
models in experimental animals (11-14;17), the renal hemodynamic profile with 
g lomerular hyperfiltration and hypertension in obesity is assumed to be a pathogenetic 
factor in the susceptibility to progressive renal function loss by hypertensive glomeru lar 
capillary damage and the ensuing increased albumin leakage (2). In micropuncture 
studies in obese Zucker rats the elevated glomerular pressure precedes the development 
of focal sclerosis (17), but in other studies glomeru lar hyperfiltration was not a 
prerequisite for the development of structural renal damage (42;43), suggesting that 
renal hemodynamic changes are not a crucial pathogenetic factor in this model. 
Moreover, RAS blockade protects against focal sclerosis in this model withou t affecting 
renal hemodynamics (17), so the pathogenetic role of the renal hemodynamics in 
obesity-associated renal damage is not straightforward, and presumably involves 
interaction with other obesity-associated factors . 
In human, in spite of the recognition of obesity as an increasingly important renal risk 
factor (101), until recently no longitudinal data were available to document a 
pathogenetic role of renal hemodynamics in the elevated renal risk of obesity. This was 
simply due to the paucity of populations with solid data on renal hemodynamics as well 
as long term follow-up. The data described in Chapter 4, in the transplant population, 
provide the first evidence that a renal hemodynamic profile with glomerular hyperfiltration, 
as apparent from a higher FF, is a determinant of graft loss, independent of 
hypertension , proteinuria and diabetes mellitus .  These data still require confirmation in 
native kidneys . Nevertheless they strongly support the assumption that the obesity­
associated renal hemodynamic profile increases the renal susceptibility to hypertensive 
damage, by combined effects of afferent vasodilation with impaired protection against 
elevated systemic arterial pressure, and an elevated efferent vascu lar tone that further 
increases glomerular pressure. Considering the usual co-existence of obesity and 
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hypertension this alleged mechanism warrants further exploration . It is supported by 
the association of obesity, glomerular hyperfiltration and albuminuria in many experi­
mental and clinical studies (2;102). The potential of RAS-blockade to alleviate the renal 
hemodynamic consequences of obesity, along with a reduction in blood pressure, 
suggests that RAS-blockade may be a fruitful intervention to reduce the long term renal 
risks of obesity, an assumption that is supported by its beneficial effects on obesity­
associated proteinuria ( 103). Intriguingly, a higher FF was also a determinant of patient  
mortality, again independent of glomerular filtration rates, proteinuria and blood 
pressure. The mechanism underlying this association could not be derived from the 
available data. It might well be that an elevated FF reflects mechanisms that can lead 
to cardiovascular mortality, such as increased neurohumoral activation, but further 
studies are definitely needed to unravel the possible pathogenetic mechanisms that 
link FF with mortality. 
Conclusions and directions for the future 
Obesity and overweight are associated with altered renal hemodynamics, usually 
characterized by elevated filtration that can also be associated with elevated perfusion, 
elevated filtration pressure, or both, and leading to sodium retention and sodium­
induced hypertension in obesity. We found that this unfavourable renal hemodynamic 
profile is a predictor of graft loss in renal transplant recipients, supporting its 
pathogenetic impact. Taken together with analogous data in diabetes and other 
hyperfiltration conditions, these findings suggest that an obesity-associated renal 
hemodynamic profile contributes to the elevated renal risk in obesity, in interaction with 
other obesity-associated factors like hypertension and insulin-resistance. In short-term 
studies the renal hemodynamic alterations in obesity and the associated proteinuria 
were reversible by weight loss, sodium restriction, and by RAS-blockade, respectively. 
These interventions are therefore likely to have the potential to limit the renal risks of 
obesity, and deserve to be explored in long term intervention studies, as adjunct 
measures to weight reduction . The effects of novel weight loss regimens based on 
cannabinoid C B1 receptor antagonism (104) on renal hemodynamics and renal risk 
remain to be established. 
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CHAPTER 7 
Sir, 
With interest we read the editorial by Dr Wolf on obesity as a renal risk factor (1). 
We fully support the authors' view that overweight  and insulin resistance, as mediators 
of renal risk, deserve attention not only in morbidly obese patients with overt insulin 
resistance, but also in renal patients with less severe obesity. 
Recent data from our group suggest that their impact may be even larger, and also be 
relevant to subjects without overt obesity. First, we found that the relationship between 
body mass index ( B M I) and renal hemodynamics is already apparent in subjects 
without overt obesity. In 102 healthy subjects with a mean B M I  of 24.8 (range 16.1 to 
29 .7) kg/m2 a higher B M I  was significantly associated with a higher filtration fraction, 
without a threshold value. Thus , the balance between afferent and efferent glomerular 
arteriolar tone is already unfavourably altered at values of B M I  below the overtly obese 
range (2). 
Moreover, epidemiological data from the general population suggest that the effect of 
insulin resistance may also extend beyond overt obesity. In the PREVEND cohort (7676 
subjects), a higher waist-hip ratio, as an indicator of insulin resistance, was associated 
with impaired renal function - not only in obese but also in lean subjects - defined as 
a B Ml<25 kg/m2 (3), suggesting that insulin resistance can affect renal function in the 
absence of obesity. This association was independent from other risk factors , such as 
hypertension and micro-albuminuria. 
These data suggest that the mechanisms present in obese, insulin-resistant renal 
patients can also be encountered in subjects without overt obesity according to current 
definitions,  and may adversely modify the course of renal function loss .  As noted by 
Dr Wolf, it would be premature to make general recommendations. In particular, the 
relationship between B M I, nutritional status and overall risk profile in renal patients may 
not be similar to that in non-renal populations. Nevertheless ,  the data so far indicate 
that mechanisms present in overtly obese and/or insulin resistant subjects may be 
relevant in much larger populations than assumed so far - and definitely deserve 
further exploration as to their relevance in renal patients . 
Renate J. Bosma 
Paul E.  de Jong 
Gerjan Navis 
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Het v66rkomen van overgewicht (body mass index ( B M I) tussen 25 en 30 kg/m2) en 
obesitas (body mass index grater dan 30 kg/m2 ; ziekelijke vetzucht) neemt sterk toe en 
dreigt - door de  ermee samenhangende ziekten - het grootste gezondheidsprobleem 
van de 2 1 ° eeuw te warden .  Obesitas gaat samen met een verhoogde kans op hart- en 
vaatziekten . Verscheidene oorzaken dragen daartoe bij . Om te beginnen leidt obesitas 
vaak tot suikerziekte of het voorstadium daarvan , de zogenaamde insu lineresistentie. 
Verder leidt obesitas vaak tot hoge bloeddruk en een verhoogd vetgehalte in het bloed . 
In de Verenigde Staten (VS) heeft momenteel bijna 65% van de inwoners overgewicht, 
terwijl er bij ruim 30% sprake is van obesitas . De situatie in Nederland is weliswaar 
minder ernstig, maar toch is bij zo'n 40% van de bevolking sprake van overgewicht en 
bij 10% van obesitas. Hoewel behandelingsmogelijkheden voor hart-en vaatziekten en 
voor suikerziekte aanzienlijk verbeterd zijn , is dit toch een zorgelijke ontwikkeling. 
Ook voor het ontwikkelen van nierschade is obesitas een risicofactor. Het is al lange 
tijd bekend dat ernstige vetzucht de oorzaak kan zijn van een ziektebeeld met 
progressieve nierschade en eiwitverlies in de urine. B ij patienten met een nierziekte 
door een andere oorzaak, en bij niertransplantatiepatienten , kan obesitas het verlies 
van nierfunctie versnellen . Op dit moment is de situatie wereldwijd dusdanig dat het 
aantal mensen met obesitas en overgewicht blijft toenemen en er moet warden 
gevreesd dat overgewicht en obesitas in de  nabije toekomst zullen uitgroeien tot de 
belangrijkste risicofactoren voor nierschade. B ij het ontstaan van die nierschade spelen 
de hoge bloeddruk, suikerziekte en insu lineresistentie die het gevolg zijn van de 
obesitas waarschijnlijk een belangrijke rol. Veranderingen in de bloeddoorstroming van 
de nier, de renale hemodynamiek, zijn betrokken bij de schadelijke effecten van hoge 
bloeddruk en suikerziekte op de nier. Ook obesitas heeft waarschijnlijk ongunstige 
effecten op de renale hemodynamiek, niet alleen door het samengaan met hoge 
bloeddruk of suikerziekte, maar ook los daarvan . Beter begrip van de afwijkingen in de 
renale hemodynamiek en het schadelijke effect van obesitas en overgewicht op de nier 
is van klinisch belang, omdat de afwijkingen in de renale hemodynamiek in principe 
met geneesmiddelen corrigeerbaar zijn . 
Dit proefschrift onderzoekt daarom de relatie tussen overgewicht en obesitas, renale 
hemodynamiek en nierschade bij de mens. In d ierexperimentele studies is al geruime 
tijd geleden aangetoond dat afwijkingen in de renale hemodynamiek de nier kunnen 
beschadigen .  B ij de mens bestaan hierover echter slechts indirecte aanwijzingen ,  
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vooral omdat er vrijwel geen studies bestaan waarin meting van de renale hemodynamiek 
werd gecombineerd met langdurige follow-up van de patienten. Wei zijn in kleine series 
patienten, met veelal zeer ernstige obesitas - met doorgaans oak hoge bloeddruk en/ 
of suikerziekte - afwijkingen in de renale hemodynamiek gevonden die op grand van 
dierexperimentele studies als ongunstig warden beschouwd. Over de renale hemody­
namiek bij minder extreme vormen van obesitas is echter nauwelijks iets bekend, 
hoewel dit een veel grater aantal mensen betreft. 
Het Universitair Medisch Centrum in Graningen heeft al ruim 30 jaar ervaring in het 
meten van renale hemodynamiek met behulp van de merk-stoffen iothalamaat en 
hippuran , voor de meting van respectievelijk de glomerulaire filtratiesnelheid (GFR; de 
belangrijkste maat voor nierfunctie) en effectieve renale plasmaflow ( ERPF, een maat 
voor de bloeddoorstraming van de nier). Uit de verhouding van die twee, uitgedrukt als 
filtratiefractie (FF), kan een indruk warden verkregen over de bloeddruk in de filtrerende 
haarvaatjes in de nier. Een te hoge druk in de haarvaatjes leidt weliswaar op korte 
termijn tot een stijging in nierfunctie, maar kan op de langere termijn de nier 
beschadigen. Oeze meting, die beschouwd wordt als de gouden standaard voor nier­
functiemeting, wordt verricht bij specifieke patientengraepen, zoals patienten die een 
niertransplantatie hebben ondergaan, maar oak bij mensen die warden gekeurd 
alvorens een nier af te staan, en bij gezonde vrijwilligers in het kader van wetenschappelijk 
onderzoek. De beschikbaarheid van een grate hoeveelheid metingen en patienten­
gegevens biedt een uitstekende mogelijkheid de relatie tussen overgewicht, obesitas, 
renale hemodynamiek en nierschade in verschillende populaties in detail te 
bestuderen. 
In de klinische praktijk, of voor epidemiologische screening, beschikt men meestal niet 
over de door ans gebruikte nierfunctiemeting. Vaak wordt daaram gebruik gemaakt van 
de zogenaamde nierfunctie-formules, waarvoor alleen het kreatininegehalte in het 
bloed nodig is om de nierfunctie te berekenen. Dit is namelijk gemakkelijk en goedkoop. 
Deze formules hebben echter aanzienlijke tekortkomingen. Een daarvan is, dat de 
uitkomst ervan gestoord wordt door verschillen in lichaamsbouw, zoals bij overgewicht 
en obesitas. Daardoor kan een systematische tout in de nierfunctieschatting optreden 
die het onderzoeken van de relatie tussen overgewicht/obesitas en nierfunctie stoort. 
In hoofdstuk 2 onderzochten we of een dergelijke systematische tout optreedt bij 




warden patienten namelijk meestal zwaarder door het wegvallen van de dieet­
beperkingen, samen met de (eetlust-versterkende) medicijnen (prednisolon). We 
vonden inderdaad een dergelijke systematische fout bij alle onderzochte formules. De 
meest gebruikte formule, de MORD formule, onderschatte de GFR meer naarmate de 
BM I toenam. De eveneens veel gebruikte Cockcroft-Gault formule daarentegen gaf 
juist een forse overschatting van de GFR bij toenemende BMI. Bij gebruik voor het 
vervolgen van de nierfunctie in de individuele patient, was de systematische afwijking 
van de formules minder storend, maar desondanks is uit onze gegevens duidelijk dat 
de beschikbare formules verre van ideaal zijn. Voor analyse van de rol van overgewicht 
en obesitas op de nierfunctie zi jn ze dan oak niet geschikt, en onze verdere studies 
wordt alleen gebruik gemaakt van de gouden standaard-methode. 
Er zijn veel (dier)experimentele studies waarin de invloed van obesitas op de renale 
hemodynamiek wordt onderzocht. Studies bij de mens zi jn echter zeldzamer, en 
betreffen vrijwel uitsluitend mensen met ernstige vetzucht. In hoofdstuk 3 onderzochten 
we daarom de relatie tussen BMI en renale hemodynamiek bij gezonde personen met 
een BMl<30 kg/m2 • In deze populatie ging een hogere BMI gepaard met een hogere 
FF. Overgewicht was dus geassocieerd met een ongunstige verandering in renale 
hemodynamiek, zonder dat er sprake was van (ernstige) obesitas, en zonder een 
duidelijke ondergrens van BMI voor wat betreft de invloed op de nier. Dit sluit aan bij 
recente epidemiologische gegevens die laten zien dat het lange termijn risico op 
nierschade niet beperkt is tot personen met manifeste obesitas, maar oak al 
aantoonbaar is bij overgewicht. Onze resultaten laten oak zien dat de invloed van BM I 
op de renale hemodynamiek in principe niet afhankelijk is van bijkomende aandoeningen 
zoals hoge bloeddruk en suikerziekte. Wei was een relatie met de leeftijd aanwezig. In 
personen met een hogere BMI verliep namelijk de daling van GFR (zoals die altijd wordt 
gezien met toenemen van de leeftijd) meer uitgesproken. Omdat het hier een dwars­
doorsnede onderzoek (dat wil zeggen, op een moment in de tijd gemeten) betreft, moet 
de relatie met leeftijd echter voorzichtig warden ge'interpreteerd. Ons onderzoek recht­
vaardigt de hypothese dat veranderingen in renale hemodynamiek betrokken zijn bij 
het ontstaan van nierschade ten gevolge van overgewicht, maar om deze hypothese 
daadwerkelijk te bewijzen, zou lange termijn vervolg onderzoek nodig zijn. Het zou 
daarbij overigens interessant zijn om het effect van bijkomende aandoeningen zoals 
hoge bloeddruk en suikerziekte te analyseren. 
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We bespraken al, dat obesitas bij patienten met een nierziekte een ongunstig effect op 
het beloop van de nierschade kan hebben. In hoeverre een hogere BMI oak bij 
nierziekte een ongunstig effect heeft op de renale hemodynamiek is tot dusverre 
onbekend. In hoofdstuk 4 onderzochten we daarom de relatie tussen overgewicht en 
obesitas, de renale hemodynamiek, en de uiteindelijke prognose bij niertransplantatie 
patienten. De eerste vraag was of BMI van invloed is op de renale hemodynamiek bij 
deze patienten, omdat de resultaten van studies bij "eigen" nieren niet direkt kunnen 
warden vertaald naar de getransplanteerde nier. Deze is namelijk in meerdere opzichten 
wezenlijk anders. Ten eerste moet deze ene nier "al het werk" alleen doen, hetgeen 
waarschijnlijk effect heeft op de renale hemodynamiek. Ten tweede is de nier ten tijde 
van de operatie enige tijd buiten een menselijk lichaam geweest, waardoor schade kan 
zijn ontstaan. Ten derde warden na transplantatie afweeronderdrukkende medicijnen 
voorgeschreven die de haarvaatjes in de nier kunnen beschadigen. Daarnaast is het 
waarschijnlijk relevant dat de getransplanteerde nier geen eigen zenuwvoorziening 
meer heeft. In vergelijking met een "eigen nier" reageert deze dus anders - of niet - op 
signalen die door het lichaam warden afgegeven. De getransplanteerde nier is oak nag 
om een andere reden interessant: de erfelijke eigenschappen en achtergronden van de 
nier en de ontvanger zijn immers verschillend. Het is dus om verschillende redenen 
interessant na te gaan of een hogere BMI van de ontvanger van de nier gekoppeld is 
aan een specifiek hemodynamisch profiel in de getransplanteerde nier. Nag 
interessanter, en van klinisch belang, zou het zijn te weten of een verband tussen een 
hogere BM I en slechtere prognose van de getransplanteerde nier toe te schrijven valt 
aan veranderde renale hemodynamiek. Om deze twee vragen te beantwoorden onder­
zochten we eerst in een dwarsdoorsnede onderzoek het verband tussen BMI en renale 
hemodynamiek in een grate groep niertransplantatiepatienten, 1 jaar na transplantatie. 
Net als bij de gezonde personen beschreven in het vorige hoofdstuk, vonden we oak 
na niertransplantatie een hyperfiltratie profiel, met een hogere FF in patienten met een 
hogere BM I. Met andere woorden: de donor-nier "weet" of hij zich in een slanker dan 
wel dikker lichaam bevindt. Het verband tussen BM I en renale hemodynamiek stand las 
van het feit of de patienten wel of geen suikerziekte hadden. Oak 5 jaar na transplantatie 
was nag steeds een verband aanwezig tussen BM I en renale hemodynamiek. Een 
lagere GFR of een hogere FF, bleken, las van elkaar en van andere risicofactoren, 
voorspellend voor de kans op transplantaatfalen, al dan niet door overlijden van de 
patient. Verder waren een lagere GFR en een hogere BMI eveneens voorspellend voor 
het optreden van transplantaatfalen nadat de overleden patienten buiten beschouwing 
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waren g elaten .  Deze gegevens ondersteunen de hypothese dat de verander ingen in 
rena le h emodynamiek d ie  warden gezien bij overgewicht een oorzakelijke rol spelen bij 
chron isch progressieve nierschade. Voor zover ons bekend is dit de eerste stud ie b ij de 
mens die de ongunst ige prognostische betekenis aantoont van een hogere FF voor de 
n ie rfunct ie op de lange term ijn .  
Zoa ls  h ie rboven beschreven kan hyperfiltratie bij de mens warden opgespoord door de  
n ierfunct ie te  meten met speciale merkstoffen .  De interpretatie daarvan i s  echter lastig 
als de  totale GFR normaal of verlaagd is .  Er kan dan op n iveau van de individue le nier­
filtertjes wel degelij k sprake zijn van hyperfiltratie, bijvoorbeeld als funct ionerend 
n ierweefsel verloren is gegaan.  Via een omweg ,  het meten van de reserve capaciteit 
van de nier, kan desondanks een indruk warden gekregen over de aanwezigheid van 
eventuele hyperfiltratie .  De n ier  heeft normaal gesproken een g rate reserve , zoals blijkt 
uit de stijg ing van GFR en ERPF in de resterende nier na n ierdonat ie ,  of tijdens zwan­
gerschap. Een afname in  reservecapaciteit wordt wel beschouwd als een teken van 
hyperfiltratie. Een maat voor de reservecapaciteit kan warden gekregen door toediening 
van vaatverwijders zoals dopamine en aminozuren ,  die leiden tot vaatverwijd ing v66r 
respectievel i jk na het n ierf i ltertje .  De combinat ie van beide geeft maxi male vaatverwijding 
met daardoor toename van GFR en ERPF: deze stijg ing wordt beschouwd als maat 
voor  de reservecapaciteit . Als functionerend nierweefsel verloren gaat, bijvoorbeeld 
wanneer een n ier verwijderd moet warden in verband met ziekte , of ten behoeve van 
transp lantatie , spreekt de reste rende nier (of het resterende n ierweefsel) de 
reservecapaciteit aan ,  teneinde een zo normaal mogelijke tota le nierfunct ie te 
handhaven ,  en dit u it z ich als een m inder sterke respons op de bovengenoemde 
vaatverwijders.  In  hoofdstuk 5 onderzochten we de relat ie tussen BMI ,  renale hemo­
dynamiek  en renale reservecapaciteit voor en na het afstaan van een n ier  (donatie) . 
We testten h iermee of het renale hemodynamische patroon bij overgewicht een 
afspiegel ing zou kunnen zijn van hyperfiltratie. Zo ja,  dan zou bij een hogere BM I  
sprake moeten zijn van een  geringere respons op de vaatverwijders.  Zoals verwacht 
was na donatie de gemiddelde reservecapacite it kleiner geworden .  Voor donatie was 
er  geen relatie tussen BMI  en renale reservecapaciteit, maar na donat ie was de renale 
reservecapaciteit beduidend lager in donoren met een hogere BM I  dan in donoren met 
lagere B M I .  D it suggereert dat het renaal hemodynamisch patroon bij een hoge BMI  
inderdaad berust op het aanspreken van de filtrat ie-reserve. Ook de relatie tussen 
leeftijd en  reservecapaciteit vertoonde een derge l i jk  patroon .  Voor donatie was er geen 
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relatie tussen leeftijd en reservecapaciteit, maar na donatie was de reservecapaciteit 
lager in oudere donoren. Dit suggereert dat oak bij het ouder warden de reserve­
capaciteit van de nieren wordt aangesproken. 
Het proefschrift wordt afgesloten met hoofdstuk 6, waarin een overzicht wordt gegeven 
van de literatuur over de relatie tussen BMI en renale hemodynamiek, en de pathofysi­
ologische consequenties daarvan. Hierin concluderen we dat obesitas en overgewicht 
gepaard gaan met veranderingen in renale hemodynamiek, gekenmerkt door een 
hyperfiltratieprofiel dat zich doorgaans uit in een verhoogde FF. Deze veranderingen 
kunnen niet alleen schade aan de nierfiltertjes toebrengen, ze zorgen er oak voor dat 
de nieren onvoldoende zout uit het lichaam verwijderen, hetgeen tot verhoogde 
bloeddruk aanleiding kan geven. Dit is niet alleen schadelijk voor de nier, maar oak 
voor hart en bloedvaten. Onze studie in transplantatiepatienten heeft laten zien dat een 
dergelijk renaal hemodynamisch profiel inderdaad prognostisch ongunstig is. Op grand 
van deze resultaten is het logisch te veronderstellen dat de effecten van overgewicht op 
de renale hemodynamiek tevens bijdragen aan de kwetsbaarheid van de nier voor de 
gevolgen van suikerziekte en/of hoge bloeddruk. 
Zoals eerder vermeld baart de toenemende prevalentie van overgewicht en obesitas 
veel zorgen. In studies uit het verleden bleek een hoge BMI samen te gaan met een 
toegenomen sterfte, vooral in de jongere leeftijdscategorieen. In recenter onderzoek 
echter is in de categorie personen met een BMI tussen de 25 en 30 kg/m2 juist sprake 
van een lagere sterfte dan in de lagere BMI categorieen, en zelfs in de categorie 30-35 
kg/m2 lijkt er geen oversterfte te zijn. Betekent dit dat het wel wat meevalt met de risico's 
van overgewicht? Het is hierbij belangrijk in ogenschouw te nemen dat sinds de jaren 
'70 van de vorige eeuw een afname van de totale sterfte aan hart- en vaatziekten wordt 
waargenomen. Dit komt door een gecombineerd effect van betere behandeling van het 
hartinfarct, verhoogde bloeddruk, verhoogd cholesterolgehalte en suikerziekte met 
medicijnen en leefregels. Omdat deze aandoeningen vooral voorkomen bij overgewicht 
en obesitas, treft de daling van de totale sterfte vooral deze groep personen - dit wordt 
met name gezien in de oudere leeftijdscategorie. De daling in sterfte betekent echter 
nag niet, dat dikkere mensen gezonder zijn dan slanke, het is eerder zo, dat ze aan de 
aan de overgewicht-gerelateerde aandoeningen niet meer overlijden. Daar komt nag bij 
dat overgewicht en obesitas juist weer beschermen tegen andere, potentieel levensbe­
dreigende, aandoeningen zoals heupfracturen, aandoeningen aan de luchtwegen en 
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infecties. Met andere woorden, ouderen met een verhoogde BMI leven relatief langer 
dan hun slankere leeftijdsgenoten. Het is aannemelijk dat dit meespeelt in het 
toenemende belang van overgewicht als oorzaak voor nierschade: door de verbeterde 
overleving bij hart-en vaat-ziekten is er immers "meer tijd" om chronische nierschade 
te ontwikkelen, een zorgelijk scenario waar derhalve ernstig rekening mee moet warden 
gehouden, zoals ook al werd aangestipt aan het begin van deze samenvatting. 
Het is echter wel bemoedigend te realiseren dat het ongunstige renale hemodynami­
sche profiel bij overgewicht en obesitas gunstig kan warden be"invloed door gewichts­
verlies en met medicijnen die ingrijpen in het renine-angiotensine systeem, zoals 
angiotensine converting enzyme (ACE)-remmers en angiotensine receptor antagonis­
ten. Een recente studie van onze groep toonde bovendien aan dat ook een zoutbeperkt 
dieet de effecten van overgewicht op de renale hemodynamiek corrigeert. Logischerwijs 
is gewichtsreductie de belangrijkste maatregel voor risicoreductie. Duurzame gewichts­
reductie is over het algemeen echter moeizaam, al lijkt een relatief nieuw middel, de 
cannabis receptor antagonist Rimonabant®, mogelijk enig perspectief te bieden in 
risico groepen. Onze gegevens suggereren dat interventie in de renale hemodynamiek, 
hetzij door medicatie, hetzij door zoutbeperking, de nier zou kunnen beschermen tegen 
de schadelijke gevolgen van overgewicht. Of dat daadwerkelijk zo is, moet echter in 
lange termijn studies warden uitgezocht. 
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Dankwoord 
Een mooi moment, het kunnen gaan schrijven van een dankwoord. Wei een vreemd 
idee dat het boekje bijna klaar is. Het heeft de afgelopen jaren deel uitgemaakt van mijn 
!even, zonder dat het er nu echt een zware stempel op drukte. Toch kijk ik uit naar de 
vrijgekomen uren die ik straks op een andere manier kan gaan invullen. 
Dit proefschrift had nooit zonder de hulp van anderen tot stand kunnen komen. 
Heel graag wil ik de volgende mensen hiervoor bedanken. 
Prof. dr. G.J .  Navis, beste Gerjan. Begin 2001 kwam ik naar Groningen voor mijn 
vervolgopleiding interne geneeskunde. In oktober van datzelfde jaar zou ik gaan beginnen 
met het aandachtsgebied nefrologie. l k  had laten vallen dat ik best wel " wat onderzoek" 
zou wil len doen, omdat dat goed voor mij zou zijn, omdat ik daarvan zou kunnen leren. 
lk weet nog goed dat jij mij "tacklede" bij het liftenblok op de vierde verdieping en mij 
vertelde dat je een fantastisch idee had voor een onderzoek, wat best eens tot een 
promotie zou kunnen leiden. Mijn eerste reactie was: "Als het maar niet met ratten is" 
(dit geeft een indruk van wat mijn beeld van jou tot dusverre was). Gelukkig gingen we 
niets met ratten doen, maar iets met (te zware) mensen. Al snel had jij een raamwerk 
klaar voor het onderzoek en ook daarna zat jij altijd vol goede ideeen. lk bewonder je 
dan ook zeer om je enorme drive, je creativiteit, je heldere denkstijl en je vermogen 
het enigszins kromme engels van mij in de beginfase om te buigen in goed leesbare 
stukken. Daarnaast wist je ook dat mijn prioriteit altijd bij de patientenzorg lag (en ligt) 
en heb ik nooit enige druk ervaren van jouw kant, iets waarvoor ik je zeer erkentelijk 
ben. Tot slot wil ik je bedanken voor het feit dat je me kennis hebt laten maken met 
Mme Ramotswe van het First Ladies Detective Agency: deze " traditionally-built woman" 
ga ik nooit meer vergeten! 
Prof. Dr. P. E. de Jong, beste Paul. Ook jij was enthousiast toen je hoorde dat ik wilde 
promoveren. Je dacht mee over hoe ik dit zou kunnen inpassen in de opleiding. In de 
beginfase was je actief bij het onderzoek betrokken. Als een stuk naar mijn idee af was, 
had jij vaak nog een goede aanvulling. Later werd jouw rol iets minder prominent, mede 
omdat je op een gegeven ogenblik onverwacht in het ziekenhuis werd opgenomen en 
je gedurende langere tijd niet beschikbaar kon zijn. Het was een rare tijd, waarin we ons 
allemaal realiseerden dat het leven zeer kwetsbaar is. 
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Dr. J. J. Homan van der Heide, beste Jaap. Dit onderzoek had niet kunnen plaatsvinden 
zonder de enorme database met niertransplantatiepatienten, ooit door Adam Tegzess 
opgezet en nu onder jouw zorgvuldige beheer. Oak jij deed ans schrikken toen je 
plotseling patient werd. Gelukkig viel het achteraf mee. lk waardeer het zeer dat je mijn 
co-promotor bent. 
De niertransplantatiepatienten-database werd in die tijd nauwkeurig bijgehouden door 
Geertien en Regien. Dames: dank voor jullie hulp bij het zoeken naar gegevens! 
Voor het meeschrijven aan de artikelen gaat mijn dank uit naar Erik Jan Oosterop, 
Carolien Doorenbos, Coen Stegeman, Jan Krikken, Arjan Kwakernaak en Mieneke 
Rook. Erik Jan was betrokken bij het eerste artikel. Carolien, wij beten ans tegelijkertijd 
vast in de formules. Coen, dank voor de waardevolle aanvullingen bij het formule-stuk. 
Zoals je weet maak ik nag steeds at en toe gebruik van je "know-how" !  Jan, dank voor 
je bijdrage aan het review artikel en de mooie figuurtjes. Arjan, jouw nimmer aflatende 
enthousiasme en doorzettingsvermogen zullen mij bijblijven. En Mieneke, op het laatst 
kon het mij niet snel genoeg gaan en was jouw donoren-stuk hetgeen waar ik op 
wachtte. Het is het wachten waard geweest! 
Beste Winie, oak jou wil ik bedanken voor de kopjes thee en het bijpraten in de Kidney 
Alley als ik weer eens een middagje in het UMCG was. 
Tevens wil ik alle mensen bedanken met wie ik samenwerkte tijdens mijn opleiding 
tot nefroloog. Het zijn er teveel ze allemaal te noemen, maar ik maak graag een 
uitzondering voor mijn kamergenoten uit die tijd. Op het DCG was dat Wybe Douwe 
Kloppenburg, alwaar het onderzoek een aanvang nam. Wybe Douwe, dank voor de 
hulp bij de excelfiguurtjes (toen ik er nag niet zo bedreven in was) en de gezelligheid. 
Na Wybe Douwe kwam lngwer Huisman mij daar gezelschap houden. lngwer, ik hoop 
dat we, net als nu, de komende jaren zo nu en dan contact hebben. Daarna deelde ik 
in het UMCG een kamer met Ron Gansevoort. Ron, ik heb hier goede herinneringen 
aan overgehouden. We memoreren nag vaak de avondjes die we daar doorbrachten 
vanwege de deadline voor de ASN (onder de klanken van het kerstkoor) ! Later schoof 
ik een paar kamertjes op naar dat van Eltjo de Maar. Eltjo, ik ben inmiddels helemaal 
over op Apple en begrijp nu eindelijk jouw preoccupatie! 
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Na de  opleidingstijd in het U MCG began ik als internist in het Meander Medisch 
Centrum in Amersfoort. Er was op dat moment nog maar 1 artikel gepubliceerd, maar 
van meet af aan heb ik gezegd dat het af zou komen .  lk ben de maatschap internisten 
dan ook zeer erkentelijk voor het feit dat zij hier altijd in heeft geloofd en mij ruimschoots 
de gelegenheid heeft geboden dit tot een goed einde te brengen .  
En dan nu  familie: lieve papa en mama, dank voor jullie altijd warme belangstelling 
en bemoedigende woorden . Lieve Niels, ik hoop dat het voor jou in 2009 zover is . 
Hartstikke goed dat je je onderzoek weer hebt opgepakt en volgens mij wordt het heel 
goed en jij beroemd! 
Tot slot: lieve Jos, zonder jouw steun was het helemaal niet gelukt. Er waren zeldzame 
momenten van stress en paniek, maar die kwamen met jouw rust en nuchterheid altijd 
weer goed. Je protesteerde nooit als ik toch een keer in een weekend aan het boekje 
moest werken , heel veel dank voor je tijd en begrip. lk kijk heel erg uit naar de tijd die 
hierna komt, als we met ons drieen zijn ! 
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